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1 INTRODUCTION 
 
 
“ Trying to describe the process of becoming an alcoholic is like trying to describe air. It’s too 
big and mysterious and pervasive to describe. […] It’s a slow, gradual, insidious, elusive 
becoming. “  
(KNAPP 1996) 
 
 
In Germany, more than 9 million people consume alcohol in a manner posing a risk to health, 
1.3 million are considered to be alcohol dependent. Just about 10 per cent undergo therapy – 
often much too late after 10 to 15 years of dependence. 20 per cent of the 12- to 25-year-old 
adolescents consume alcohol in regular terms. The economic costs of alcohol-related 
diseases are estimated to amount to 20 billion Euro per year. Each year, 42.000 people die 
either directly (via alcohol abuse) or indirectly (e.g. via accidents caused by alcohol) of the 
consequences of alcohol consumption (German Federal Ministry of Health). Contemplating 
all these facts, alcohol misuse is among the biggest social problems worldwide and the 
aetiology of this complex disease is thus of great interest in scientific and medical research.  
There are considerable differences in the definition of alcoholism and related 
terminology among the medical community, treatment programs, and the general public. The 
Journal of the American Medical Association (JAMA) defines alcoholism as a primary, 
chronic disease characterised by impaired control over drinking, preoccupation with the drug 
alcohol, use of alcohol despite adverse consequences, and distortions in thinking (MORSE 
and FLAVIN 1992). It is debated whether dependence as defined by JAMA is physical 
(characterised by withdrawal), psychological (based on reinforcement), or both. The 
Diagnostic and Statistical Manual of Mental Disorder, 4th edition (DSM-IV) defines alcohol 
abuse as repeated use despite recurrent adverse consequences. It further describes 
alcoholism as a chronic relapsing disorder, which is characterised by a preoccupation with 
obtaining alcohol, loss of control over its consumption, development of tolerance, 
dependence, and impairment in social and occupational functioning. According to the DSM-
IV definition, alcoholism is equivalent to Substance Dependence on Alcohol.  
 
Alcohol represents an organic compound in which a hydroxyl group (-OH) is bound to a 
carbon atom of an alkyl or substituted alkyl group. Among the different alcoholic compounds, 
the one suitable for drinking is ethanol (EtOH) (Figure 1). Ethanol is a product of the alcoholic 
fermentation process. Via this common biological reaction, glucose and water are converted 
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in the presence of ferment (usually yeast) to produce ethanol and carbon dioxide. Since any 
source of glucose is sufficient to produce alcohol via the fermentation process, it forms the 
basis of numerous alcoholic beverages worldwide (KOOB and LE MOAL 2006).  
 
 
Figure 1. Chemical structure of ethanol and other alcohols. Ethanol is also known as EtOH, using the 
common organic chemistry notation of representing the ethyl group (C2H5) with Et. 
 
Many neurobiological and environmental factors are known to influence ethanol-drinking 
behaviour, whereas the nature and extent to which these variables govern the propensity to 
drink alcohol varies among individuals (BECKER and LOPEZ 2004). In addition, inherited 
factors also contribute substantially to an individual’s susceptibility to alcohol abuse and 
alcoholism. Twin registry and adoption studies have shown that the heritability of alcoholism 
may be as high as 50-60 per cent (HIGUCHI et al. 2006). Thus, the genetic constitution and 
environmental experience interact to alter both direct alcohol actions and molecular 
mechanisms that indirectly affect ethanol-related behaviours (LOVINGER and CRABBE 2005).  
 
 
1.1 Metabolism of alcohol 
Alcohol is detoxified and removed from the blood through oxidation, preventing the alcohol 
from accumulating and destroying cells and organs. Most of the consumed alcohol is 
metabolized in the liver, but the small quantity that remains unmetabolized permits the 
measurement of alcohol concentration in breath and urine. Via the absorption in the stomach 
and the intestines alcohol is passed into the blood. Until all the consumed alcohol has been 
metabolized, it is distributed throughout the body, affecting the brain and other tissues 
(BOSRON et al. 1993). In the liver, the enzyme alcohol dehydrogenase (ADH) mediates the 
conversion of alcohol to acetaldehyde, which is then rapidly converted to acetate, water and 
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carbon dioxide by the aldehyde dehydrogenase (Figure 2a). It was shown that genetic 
variation in this pathway contributes to individual differences in alcohol elimination in human 
populations. In Asian populations for example, inactivation of the acetaldehyde 
dehydrogenase 2 (ALDH2) is believed to cause the alcohol-induced flush reaction after 
drinking alcohol (WALL et al. 1993).  
In the liver, alcohol is also metabolized by the microsomal ethanol oxidation system 
(MEOS) catalyzed by cytochrome P450IIE1-CYP2E1 (P450; Figure 2c). This pathway was 
shown to be responsible for metabolic tolerance to alcohol, as its activity is increased after 
chronic alcohol drinking (LIEBER 2005). Moreover, metabolism by P450 results in a significant 
release of free radicals, which in turn diminish reduced glutathione and other defence 
systems against oxidative stress that play a major pathogenic role in alcoholic liver disease. 
In a third reaction pathway, alcohol is metabolized in a non-oxidative way by the fatty acid 
ethyl ester (FAEE) synthase, which leads to the formation of fatty acid esters. The highest 
concentrations of FAEEs are found in organs that are vulnerable to the toxic effects of 
alcohol, including the liver (BEST and LAPOSATA 2003) (Figure 2d). Regardless to the amount 
that has been consumed, the liver only metabolizes a certain amount of alcohol per hour. 
The rate of alcohol metabolism depends, in part, on the amount of metabolizing enzymes in 
the liver, which varies among individuals and again has genetic determinants (BOSRON et al. 
1993). 
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Figure 2. Principle metabolic pathways related to ethanol and acetaldehyde metabolism. Three 
metabolic systems are responsible for the ethanol oxidation in the liver. (a) The enzyme alcohol 
dehydrogenase promotes the oxidation of ethanol into acetaldehyde, at which a nicotinamide adenine 
dinucleotide (NAD+) is reduced to NADH. (b) Hepatic cell peroxisome oxidation couples ethanol 
oxidation into acetaldehyde with the simultaneous degradation of hydrogen peroxide, which is 
catalyzed by the catalase enzyme. (c) The microsomal ethanol oxidizing system (MEOS) couples 
ethanol and nicotinamide adenine dinucleotide phosphate (NADPH) oxidation, which requires 
cytochrome P450 participation. MEOS is distinguished from alcohol dehydrogenase by its subcellular 
localization, its pH optimum, and its cofactor requirements. (d) Fatty acid ethyl ester synthase 
catalyzes the non-oxidative alcohol metabolism pathway. (Modified according to KOOB and LE MOAL 
2006.) 
 
1.2 Neurobiological effects of alcohol 
Despite the generally held view that alcohol is an unspecific pharmacological agent, recent 
molecular pharmacology studies demonstrated that alcohol has several primary targets. 
These are the N-methyl-D-aspartic acid (NMDA), γ-aminobutyric acid (GABA), glycine, 5-
hydroxytryptamine-3 (serotonin, 5-HT) and nicotinic acetylcholine receptors (nAChR) as well 
as L-type Ca2+ channels and G-protein-activated inwardly rectifying K+ channels (VENGELIENE 
et al. 2008; WANG et al. 1994). In addition, alcohol intake also evokes several indirect effects 
on a variety of neurotransmitter/neuropeptide systems, which together lead to the common 
acute effects of alcohol. Once alcohol drinking becomes chronic, several changes in the 
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brain take place. Mainly, the balance between inhibitory and excitatory neurotransmission 
through different transmitter systems is altered in this phase of the disease. The specific 
neurotransmitter systems most studied in alcoholism research (at the cellular level) are 
probably GABA and glutamate (VENGELIENE et al. 2008) (Figure 3).  
 Alcohol exposure is known to enhance GABAA receptor function. Chimeric receptor 
constructs that combined sections of the GABA ρ1 (which are – although evolutionary related 
to ionotropic GABAA receptors - inhibited by ethanol) and glycine receptors (whose currents 
are enhanced by ethanol) were used to identify a small region of amino acids required for the 
enhancement of GABAA and glycine receptor function by alcohol (MIHIC and HARRIS 1996). 
Two amino acids in the GABAA receptor transmembrane segments (TM) 2 (Ser270) and 3 
(Ala291) were shown to be critical for allosteric modulation of GABAA and glycine receptors 
by alcohols. It was suggested that Ser270 and Ala291 are part of a hydrophobic binding site 
in pockets formed between at least two TM domains. This hypothesis was supported by the 
fact that replacing either of these two amino acids resulted in loss of ethanol potentiation 
(LOBO and HARRIS 2008; MIHIC et al. 1997). Although the alcohol - GABAA interaction was 
confirmed in several electrophysiological studies (AGUAYO et al. 2002; SOLDO et al. 1998), 
there are also in vivo and in vitro studies that could not verify this interaction (DAVIES 2003; 
MARSZALEC et al. 1998). These disparate findings demonstrate that alcohol does not 
increase GABAA-mediated inhibition in all brain regions, in all cell types in the same region, 
at all GABAA sites on the same neuron or across species in the same brain region, which 
may be due to differences in subunit composition of the receptor (KOOB and LE MOAL 2006).  
 Acute ethanol enhances the inhibitory tone of neurons containing GABAA receptors, but 
prolonged ethanol exposure leads to its reduction (GROBIN et al. 1998) showing that chronic 
but not acute alcohol use generally downregulates GABAA receptor function. The effects 
induced by chronic alcohol exposure are supposed to be mediated via a decrease in GABAA 
receptor density and brain region specific up- or downregulation of α and β subunit gene 
expression (GOLOVKO et al. 2002; SANCHIS-SEGURA et al. 2007; VENGELIENE et al. 2008). 
Behavioural studies using knockout mice that are deficient for different GABAA receptor 
subunits demonstrated that α1, α2, α5 and δ subunit deletion leads to lower alcohol 
consumption (CRABBE et al. 2006b; JUNE et al. 2007; VENGELIENE et al. 2008). Further, 
protein kinase C (PKC) activity appears to be a critical determinant of alcohol actions on 
GABAA receptors. Thus, mice lacking the ε isoform of PKC showed increased sensitivity of 
GABAA receptors to allosteric modulation by alcohol and are known to consume less alcohol 
(HODGE et al. 1999). In contrast, GABAA receptors are less sensitive to alcohol effects in 
mice lacking PKCγ (HARRIS et al. 1995) and accordingly PKCγ knockouts show increased 
voluntary alcohol consumption (HODGE et al. 1999). Hence, PKCε and PKCγ may mediate 
phosphorylation of GABAA receptors and thus regulate alcohol drinking in opposite ways. 
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Due to variations in PKC isoform expression in different brain regions, this regulation may 
depend on the regions involved (KOOB and LE MOAL 2006).  
There is also evidence that metabotropic GABAB receptors might play a crucial role in 
controlling the levels of chronic alcohol intake. Studies with alcohol-preferring rat lines 
revealed that the GABAB agonist baclofen suppresses voluntary alcohol consumption. 
However, repeated use of baclofen might lead to the development of tolerance (COLOMBO et 
al. 2000). Another study referring to this showed that co-administration of a positive allosteric 
modulator of the GABAB receptor such as CGP7930 enhances the potency of baclofen and 
reduces the development of tolerance (ADAMS and LAWRENCE 2007). 
 
Since the late 1980’s and early 1990’s it is known that ethanol also acts by inhibiting 
neuronal NMDA receptor function (HOFFMAN et al. 1989; LOVINGER et al. 1989) and the 
NMDA receptor is now considered as one of the primary molecular targets for the actions of 
ethanol in the brain. As NMDA receptors are heterotetrameric protein complexes that form 
ligand-gated ion channels, they are composed of at least one NR1 subunit (for which there 
are at least 8 splice variants) and a combination of NR2A-D and NR3A or 3B subunits 
(STEPHENSON 2006). The receptors containing NR2B subunits are particularly sensitive to 
inhibition by ethanol, whereas NR2C and NR3 subunit-containing receptors appear to be less 
sensitive (GASS and OLIVE 2008). As examined in cultured rat cortical neurons, the inhibition 
of NMDA receptor function is mediated by a non-competitive mechanism (WIRKNER et al. 
2000). In the rat dorsal striatum, ethanol exposure produced an increase in NR2B subunit 
phosphorylation, and a corresponding increase in the activity of Fyn kinase, which 
phosphorylates NR2B (WANG et al. 2007). The influence of alcohol on glutamate signalling is 
robust and not as dependent upon brain region or cell type as the alcohol effects on the 
GABAA receptor for example. Alcohol-induced changes in glutamate signalling pathways are 
observed in most neuron types in brain regions like the cerebral cortex, nucleus accumbens, 
septum, amygdala, hippocampus, locus coeruleus, VTA and cerebellum (for review see 
GASS and OLIVE 2008). The ability of ethanol to inhibit NMDA receptor function is dependent 
on its heteromeric subunit composition. For example, the NR1-2b splice variant that is co-
assembled with the NR2C subunit was shown to be most sensitive to ethanol-induced 
inhibition among 32 NR1/NR2 subunit combinations expressed in HEK293 cells (JIN and 
WOODWARD 2006). Further, the extracellular Mg2+ and glycine concentrations, intracellular 
Ca2+ concentrations, and the phosphorylation by proteins kinases such as Fyn, PKA, and 
PKC as well as by the phosphorylation regulator DAARP-32 impact on ethanol-induced 
receptor inhibition (for review see GASS and OLIVE 2008). 
In response to constant inhibition of NMDA receptor function, chronic alcohol use and 
alcohol withdrawal leads to an upregulation of various NMDA receptor subunits including the 
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NR1, NR2A and NR2B subunits in the cerebral cortex and hippocampus (FOLLESA and TICKU 
1995; TREVISAN et al. 1994). Induced by chronic ethanol, NR1 expression is also upregulated 
in the VTA and amygdala (ORTIZ et al. 1995), regions that are critical for the reinforcing 
effects of ethanol. Additionally, NMDA receptor conductance and cation influx as well as 
synaptic clustering is increased (BLEVINS et al. 1995; FLOYD et al. 2003; NAGY et al. 2003). 
As a result of ethanol-induced upregulation of NMDA receptor expression, the central 
nervous system enters a state of hyperexcitability upon acute withdrawal from ethanol 
exposure (TSAI and COYLE 1998; TSAI et al. 1995). Following prolonged ethanol withdrawal, 
NMDA receptor expression and functionality are reduced (ROBERTO et al. 2006). A similar 
action of alcohol was discovered for non-NMDA glutamate receptors like the kainate or the α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor (CARTA et al. 2003; 
MARTIN et al. 1995; ROBERTO et al. 2004), although these receptors appear to be less 
sensitive to inhibition by ethanol than NMDA receptors, requiring concentrations of 50 mM or 
greater (GASS and OLIVE 2008). 
 
Other ionotropic receptors were also characterized as primary targets for the action of 
alcohol. Thus, glycine receptor activity is enhanced by alcohol and it potentiates 5-HT3 
(LOVINGER 1999) and neuronal nAChR function (NARAHASHI et al. 1999). Other studies 
revealed that alcohol (and acetaldehyde) in intoxicating doses activates neurons in the 
ventral tegmental area (VTA) in vivo and in vitro, partly via a direct activation of dopaminergic 
neurons in the VTA. During ethanol withdrawal, a decrease in dopaminergic activity in the 
VTA was linked to the dysphoria of acute and protracted withdrawal (DIANA et al. 1993). This 
reduced dopaminergic transmission is prolonged, thus outlasting the physical signs of 
ethanol withdrawal (BAILEY et al. 2000; DIANA et al. 1996). 
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Figure 3. Molecular mechanisms of neuroadaptations in alcoholism. Alcohol, by acting on 
neurotransmitter systems, affects the phenotypic and functional properties of neurons through the 
general mechanisms outlined in the diagram. Shown are examples of ligand-gated ion channels (1) 
such as the GABAA and the NMDA receptor (NMDAR), G protein-coupled receptors (R) such as 
opioid, dopamine (DA), or the cannabinoid CB1 receptors (2). These receptors modulate the levels of 
second messengers like cAMP and Ca++􏰌(3), which in turn regulate the activity of protein kinase 
transducers (4). Such protein kinases affect the functions of proteins located in the cytoplasm, the 
plasma membrane, and the nucleus (5–8). Among membrane proteins, ligand-gated and voltage-
gated ion channels are affected (6 and 7). Alcohol has been proposed to affect the GABAA response 
via PKC phosphorylation. Gi and Go proteins also can regulate potassium and calcium channels 
directly through their βγ subunits (9). Protein kinase transduction pathways also affect the activities of 
transcription factors (8). While membrane and cytoplasmic changes may only be short-lasting, 
changes of transcription factor activity may result in long-term functional changes. These can include 
changes in gene expression of proteins involved in signal transduction (10) and/or neurotransmission 
(11–13), resulting in altered neuronal responses. Chronic exposure to alcohol has been reported to 
increase levels of PKA (10) and adenylyl cyclase (11) in the nucleus accumbens and to decrease 
levels of Giα (11). Moreover, chronic ethanol induces differential changes in subunit composition in the 
GABAA and in the glutamate ionotropic receptors (12) and increases expression of voltage-gated 
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calcium channels (VGCC) (13). Chronic exposure to alcohol also alters the expression of transcription 
factors (14). CREB expression, for instance, is increased in the nucleus accumbens and decreased in 
the amygdala by chronic alcohol treatment. The receptor systems depicted in the figure may not 
coexist in the same cells. (Modified according to KOOB et al. 1998.) 
 
Ethanol intake, preference and the severity of ethanol withdrawal in animal models have 
been shown to be reduced after selective pharmacological manipulations of some of the 
respective neurotransmitter systems (NEVO and HAMON 1995). 
 
1.3 Animal models in alcoholism research 
It is not possible to model alcoholism with all its complex facets in animals. Nonetheless, 
several animal models exist that mimic distinct aspects of the disorder, most of them using 
rodents as model organisms. Animal models provide the possibility of controlling the 
environmental conditions to a great extent. Furthermore, one can separate the genetic and 
environmental influences, so that all the variance in the phenotype can be referred to the 
respective aspect of interest (GRISEL 2000). To assure that an animal model mimics the 
human conditions as closely as possible, validity criteria have been determined that should 
be considered before establishing a disease model (Box 1).  
 
Box 1. Criteria of validity 
 
Construct validity: Assesses the accuracy with which a model parallels the human condition. Construct 
validity is difficult to assess and must continuously integrate additional data from both animal and human tests. 
Aetiological validity: The causative phenomena of the model are similar or identical to those of the disorder. It 
is conceptually similar to construct validity, but is perhaps more difficult to assess because causal mechanisms 
for human psychopathologies are rarely known. 
Face validity: The phenotype of the animal model resembles the human disorder. Superficial similarity 
between animal and human measures might indicate convergence of an underlying aetiology. This assessment 
is probably a good starting point for model development but requires additional validation.  
Predictive validity: The model enables predictions about the human condition; determination necessitates 
development of appropriate measures in humans to assess the reliability of the model. 
 
(Modified according to BENNETT et al. 2006.) 
 
In alcoholism research, rats have become prominent organisms to model alcohol addiction-
related behaviours like alcohol dependence, tolerance, withdrawal, preference or 
reinstatement (relapse) (SANCHIS-SEGURA and SPANAGEL 2006; SPANAGEL 2000). Rats are 
also often utilised for pharmacological manipulations to elucidate neurobiological pathways 
involved in the development of the disease and to examine the properties of potential agents 
for treatment.  
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With regard to the molecular and genetic basis of alcoholism, mice are the most commonly 
used vertebrate model organism, because they are readily amenable to a wide spectrum of 
genetic manipulations (ABUIN et al. 2007; BRAULT et al. 2006; GAVERIAUX-RUFF and KIEFFER 
2007; SCHMIDT-SUPPRIAN and RAJEWSKY 2007). Although mice are not suitable for modelling 
all aspects of human behaviours, they have considerable genetic homology with humans (> 
99% of mouse genes have a clear human homolog) (BENNETT et al. 2006). In hypothesis-
free approaches (like quantitative trait loci analyses, see 1.5) wildtype mice are investigated 
for phenotypes with strong evidence of genetic control and subsequently examined for their 
genetic constitution. Mouse models have been developed to assess almost all aspects of 
alcohol addiction including acute effects (e.g. thermoregulation, motility), tolerance, somatic 
dependence, alcohol preference and reward as well as relapse to alcohol-seeking behaviour 
(Box 2).  
 
Box 2. Behavioural paradigms in alcoholism research. The box presents a selection of behavioural 
paradigms commonly used to assess alcoholism-related behaviours. For a more extensive description 
see section 3 Methods and the following references (CRABBE and BELKNAP 1980; CRABBE et al. 1994a; 
FONT et al. 2006; KOOB 2000; RACZ et al. 2008; SELF and NESTLER 1998; SHEPHERD et al. 1994). 
 
Acute and chronic ethanol effects: Thermoregulation after acute ethanol exposure (e.g. injection) provides 
evidence about acute ethanol effects. After chronic ethanol exposure, the direction of difference in 
thermoregulation indicates tolerance or sensitization effects. 
Forced ethanol-drinking paradigm: Produces a state of somatic ethanol dependence by forcing the animals 
to consume an ethanol solution, supplied as their only drinking source over several weeks. Alcohol 
consumption and animal responses can be monitored during the experiment. 
Two-bottle choice paradigm: Assesses ethanol preference in mice, since they have free choice between an 
ethanol solution and water. Alcohol consumption relative to total fluid intake is calculated as a preference ratio. 
Handling-induced convulsions: Evaluates somatic ethanol withdrawal signs. Ethanol withdrawal-induced 
convulsions or seizures are easy to measure via gently turning and lifting the animals and are scored by 
severity. 
Zero maze: In this maze experiment the behaviour of an animal in an anxiogenic environment can be used as 
a measure of anxiety-like behaviour in drug or non-drug states.  
Open-field: Assesses the spontaneous locomotor activity of the animals in drug or non-drug states. The 
activity exhibited in a Plexiglas box that is larger than the home cage is automatically recorded by using 
photocell beams or a video-tracking system. 
Stress responses: Exposure to a stressor (e.g. a mild foot-shock) can provoke relapse to alcohol-seeking 
behaviour in abstinent animals.  
Conditioned place preference (CPP): Reveals motivational effects of drugs of abuse in experimental animals. 
The CPP paradigm uses a classical conditioning procedure to pair different environments with distinct drug or 
non-drug states. The time spent in drug- or non-drug associated environments provides information about 
positive and negative reinforcing effects of a drug. 
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1.4 Genetics of alcoholism  
Several studies already stressed the impact of the (individual) genetic constitution on the 
development of alcohol addiction. Especially the results of human studies supported this 
hypothesis for many years, because it was shown that there is a fourfold enhanced risk of 
alcohol dependence in relatives of alcoholics and that identical twins of alcohol dependent 
subjects carry a higher risk than fraternal twins or full siblings. Additionally, adopted children 
of alcoholics have the same enhanced risk of contracting the disease as children raised by 
their alcohol dependent parent (MAYFIELD et al. 2008).  
Alcoholism has a complex aetiology in which multiple genes and environmental factors 
are involved. Complex diseases lack the simple inheritance patterns characteristic of single 
(Mendelian) gene disorders, which makes it difficult to determine the individual’s risk of 
inheriting or passing on the disease (RANNALA 2001). It is a rather daunting task to identify 
the underlying gene variants in complex diseases. The most successful studies so far have 
used candidate gene approaches where the biological evidence already suggested a 
possible involvement in the disease process. Only with the advent of chip-based 
technologies that permit the simultaneous detection of thousands of polymorphisms in each 
individual has it been possible to realize systematic whole-genome association studies 
(EBERLE et al. 2007; FAN et al. 2006; ROPERS 2007). Nevertheless, these studies are still 
discouraging and cost-intensive, because they ideally require very large sample sizes with 
more than 10.000 cases and controls. Currently, very little is known about complex genetics 
and how common gene variants contribute to disease aetiology. Common gene variants 
often do not affect the protein-coding capacity of a gene locus and thus are thought to 
change gene regulatory mechanisms. Indeed, disease-associated alleles are often unknown, 
because association studies only identify specific polymorphisms or haplotypes that are over- 
or underrepresented in the case versus the control sample. It than remains to be determined 
which of the observed polymorphisms is responsible for the increased genetic risk – a task 
that has seldom been tackled successfully so far. These small and subtle gene effects are 
difficult to address with genetically manipulated mouse strains. Although it is possible to 
generate “humanized” mice that carry gene regulatory alterations in disease-associated 
alleles, it remains to be shown how informative such mouse models will be (SHULTZ et al. 
2007).  
Previous research pointed towards a more general influence of genetic variations 
(polymorphisms) on repetitive alcohol use and associated problems. It is believed that 
disease-relevant genes influence a range of (genetically influenced) intermediate 
characteristics or endophenotypes, which subsequently affect the risk of developing alcohol 
dependence. One approach to study a complex disease is to dissect the heterogeneous 
disorder by using such intermediate (endo-) phenotypes and thus to reduce complex 
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behaviour to more homogeneous components. Endophenotypes have the advantage that the 
number of influential factors contributing to the disease should is fewer and more easily 
identifiable. Each of these endophenotypes is likely to reflect the actions of multiple genes 
and to relate to both the genetic and environmental influences (CRABBE et al. 2006b; HINES 
et al. 2005; SCHUCKIT et al. 2004).  
 
1.4.1 Linkage versus association studies 
Two basic strategies are commonly used to detect genes implicated in multifactorial 
disorders: linkage analysis and association mapping. Both approaches rely on similar 
principles and assumptions, namely on the co-inheritance of adjacent DNA variants. Linkage 
analysis tests for co-segregation of a gene marker and disease phenotype within closely 
related subjects, to determine if the marker and the disease gene are physically linked. On 
the other hand, association studies examine the co-occurrence of a marker and disease at 
the population level, usually by comparing marker frequencies in unrelated cases and 
controls. Linkage and association studies can use both ‘reverse-genetics’ (testing random, 
anonymous DNA markers) and ‘forward-genetics’ (using candidate gene polymorphisms with 
presumed functional significance for the disease), though ‘forward-genetics’ is the mainstay 
of association mapping (BARON 2001). 
For human genome-wide association approaches, the case-control study design is 
often the method of choice for characterizing the genetic contributions to the disease. It has 
recently made a tremendous impact on the analysis of complex traits. These analyses 
benefit from a very large sample size; cases are readily obtained, efficiently genotyped and 
compared with control populations (LANDER and SCHORK 1994). One particular difficulty for 
association studies is the choice of control populations. The selection of a control population 
is often biased, due to the fact that they are retrospectively defined after the collection of the 
disease group. The problem resulting from wrongly defined controls may be stratification 
effects leading to the association of allele frequency differences with the disease, although 
these differences only reflect evolutionary or migratory history, gender differences or other 
independent processes. An important drawback of association studies is the fact that 
detailed phenotype information is relegated to a secondary role. In case–control studies, the 
main indicator for underlying genetic disease susceptibility is the binary categorization of 
individuals as affected or unaffected. But addictive disorders in particular combine complex 
processes, in which different aspects of the disease are usually regulated by completely 
different genes. The future direction may therefore be the combination of linkage and 
association studies to efficiently investigate the genetics of complex diseases (KRUGLYAK 
2008).  
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1.5 Quantitative trait loci analysis 
 
“What does a QTL signify? A good QTL is a claim that a particular chromosomal region 
contains a causal source of variation in the phenotype. The importance of this hypothesis 
depends on the quality and relevance of the phenotype and the statistical strength of the 
QTL. As usual, test and be sceptical.” 
(webQTL; http://www.genenetwork.org) 
 
Drug addiction-related behavioural phenotypes are influenced by multiple gene loci, each of 
which typically contributes a small effect size. Thus, the behaviours vary by degrees and 
constitute a quantitative trait. Genetic loci contributing to these quantitative traits (quantitative 
trait loci, QTL) are identified by quantitative genetic approaches (QTL analysis). In general, 
linking genetic variation with trait variation identifies QTL and a significant linkage of 
phenotype and genotype suggest that the DNA status helps to determine trait expression.  
As stated above, mouse QTL studies provide distinct advantages over human studies 
in the examination of genetic causes of a quantitative trait (e.g. alcoholism), even in the 
absence of specific hypotheses regarding its aetiology or candidate genes. Since it is 
possible to control the experimental environment of laboratory mice and thus isolate genetic 
and environmental influences, one can attribute virtually all the variance in phenotype 
between different animal strains to genetic factors (GRISEL 2000). A common strategy in 
mouse QTL studies is based on the breeding of a suitable genetically divers population of 
mice, followed by phenotype and genotype analyses of the individuals. Typically, two or more 
inbred strains of mice are crossed for at least two generations. The progenitor mouse strains 
should have sufficient variation for the traits of interest and they should be genetically diverse 
enough to enable genetic mapping (BENNETT et al. 2006; FLINT 2003; GRISEL 2000). The 
sample size required for the identification of QTL depends largely on the effect size that a 
QTL contributes to phenotypes on interest. Inference about QTL can be made if one or more 
genetic markers are over- or underrepresented in the analysed individuals. Genotyping is 
often done by means of microsatellite markers, which contains mono, di-, tri-, or 
tetranucleotide tandem repeats flanked by specific sequences (Figure 4a). Microsatellites 
alleles at a specific locus can differ in the number of repeats among individuals (lengths 
polymorphism) - one characteristic that qualifies them as genetic markers. Furthermore, 
microsatellites are inherited in a Mendelian fashion, are widely dispersed in eukaryotic 
genomes, are highly variable, and based on polymerase chain reaction (PCR) (CULLIS 2002; 
SOUTHERN 1975), all of which are necessary conditions for mapping studies. In literature 
microsatellites are also known as simple sequence repeats (SSR), short tandem repeats 
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(STR), or variable number tandem repeats (VNTR) and have been characterized for most of 
the commonly used inbred mouse strains.  
 
 
Figure 4. (a) Schematic illustration of a microsatellite locus. The red arrows indicate repeat units; the 
black lines represent the DNA strands. Exemplary, a dinucleotide tandem repeat is shown. (b) 
Fragment lengths polymorphism of a microsatellite locus between two alleles. C: Cytidine; A: 
Adenosine.  
 
Another QTL strategy involves the phenotyping and genetic analysis of recombinant inbred 
(RI) strains, which have a unique combination of well-circumscribed genome contributions 
from two or more progenitor inbred strains. Traditionally, RI strains are derived by 
consecutive brother x sister mating (> 20 generations), starting from a first filial (F1) 
generation of an intercross of two inbred strains. More advanced RI strains, as those 
generated in the Collaborative Cross project, are derived from multiple inbred strains 
(CHURCHILL et al. 2004). In alcoholism research, previous studies already detected several 
QTL contributing to the different aspects of the disease (BENNETT et al. 2006; CRABBE 2002; 
MAYFIELD et al. 2008), whereby the specific aetiological factors underlying the susceptibility 
to alcoholism remain unknown.  
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1.6 Aim of the study 
Previous studies already identified genes that increase or reduce the risk of becoming 
alcohol-dependent. The neural basis of alcohol dependence is also more and more clarified. 
But despite all the knowledge about alcoholism and its concomitant phenomena that has 
been achieved in years of research, the specific aetiological factors underlying susceptibility 
to alcoholism remain unknown. Especially the determination of genetic factors redounding to 
the disorder is an important direction alcoholism research should follow to further understand 
this common disease. 
The aim of the present thesis therefore was the identification of gene loci or 
quantitative traits that contribute to the development and manifestation of alcohol addiction 
and related behaviours. To reach this aim, a QTL study design in mice was chosen. The 
second filial (F2) generation of a C57BL/6J and C3H/HeJ mice intercross was first 
phenotyped in paradigms related to alcohol addiction, whereas the development of a high-
throughput phenotyping protocol allowed the serial analysis of several hundred animals. By 
choosing the phenotypes described in this work and the serial experimental setup, a wide 
spectrum of alcohol-related traits within the same F2 animal cohort is addressed, which 
allows to evaluate whether these traits are regulated by common or distinct QTL. 
Subsequently, the genetic constitution of these mice was analysed by microsatellite marker 
mapping. A further aim was the establishment of a highly informative microsatellite marker 
set for the high-throughput mouse genotyping. This set finally consisted of 264 primer pairs 
showing fragment lengths polymorphisms between the alleles of the parental mouse strains 
and were distributed throughout the mouse genome. Via subsequent statistical analyses the 
data obtained from pheno- and genotyping were linked to determine QTL contributing to 
alcohol dependence and related traits.  
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2 MATERIAL  
 
2.1 Equipment 
ActiMot ActiMot, TSE Systems 
Analytical balance BP 121 S, Sartorius 
CCD camera KY-F75U, JVC 
Centrifuges Biofuge fresco, Heraeus Instruments 
Biofuge pico, Heraeus Instruments 
Biofuge stratos, Heraeus Instruments 
Sorvall Evolution RC, Kendro 
Digital gel documentation Chemi Doc Syst CCIR, Bio-Rad Laboratories 
Drinking bottles Cascade 5; Hagen, Holm 
Electrophoresis chamber Bio-Rad Laboratories 
Genetic Analyzer ABI 3130xl, Applied Biosystems 
Liquid handling platform Multiprobe II, PerkinElmer 
Magnetic stirrer MR 3001 K, Heidolph, Fisher  
Microplate Analyzer FusionTM Universal Microplate Analyzer, PerkinElmer 
PCR iCycler iCycler, Bio-Rad Laboratories 
pH meter inoLab, WTW  
Rectal thermometer Portable Thermometer BAT-12, Harvard Apparatus 
Spectral photometer 91-ND-1000 UV/Vis, Nanodrop  
Startle response system Startle Response System, TSE Systems  
Sterilising oven Varioklav 25T, H+P Labortechnik 
Video-tracking system Videomot, TSE Systems 
Vortexer Vortex-Genie 2, Scientific Industries  
Zero maze In-house workshop 
 
 
2.2 Software  
Data collection software Applied Biosystems, Version 3.0 
Fusion Instrument Control Software PerkinElmer  
GeneMapper Applied Biosystems, Version 3.7 
Microsoft Office 2008 Microsoft Germany 
R software language R, Version 2.7.2 (2008) 
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R/qtl R/qtl, Version 1.09-43 (2008) 
Statistika StatSoft, Inc., Version 6 (2001) 
WinPrep Winprep for Multiprobe II, PerkinElmer 
 
 
2.3 Chemicals and reagents 
If not noted otherwise, all reagents used in this work were purchased from Invitrogen, Carl 
Roth, Merck or Sigma-Aldrich.  
 
 
2.4 Enzymes 
All enzymes used in this work were purchased from Qiagen (Hilden, Germany) and New 
England BioLabs (NEB).  
 
 
2.5 Molecular weight standards 
Molecular weight standards were used as lengths standard in polyacrylamide (PA) gel- and 
capillary electrophoresis.  
 
Table 1. Molecular weight standards. 
 
Molecular weight standards Fragment size (bp) 
DNA 100 bp ladder (Invitrogen) 2072, 1500, 1400, 1300, 1200, 1100, 1000, 
900, 800, 700, 600, 500, 400, 300, 200, 100 
DNA 25 bp ladder (Invitrogen) 500, 475, 450, 425, 400, 375, 350, 325, 300, 
275, 250, 225, 200, 175, 150, 125, 100, 75, 
50, 25 
GS-500 ROX™ Size Standard (ABI) 35, 50, 75, 100, 139, 150, 160, 200, 250, 300, 
340, 350, 400, 450, 490, 500 
 
 
2.6 Oligonucleotides 
All oligonucleotides used in this work were synthesized and delivered by metabion 
international AG. The forward primer of each pair was labelled at the 5’ end with the 
fluorescent dye FAM, HEX or TET. All reverse primers contained the sequence GTGTCTT 
(5’–3’) at their 5’ ends to promote nontemplate-directed nucleotide addition (+ A) to the PCR 
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products. Information about primer sequences, modifications and expected fragment lengths 
are provided in Supplement table S1. 
2.7 Solutions 
6x loading dye: 
 
Glycerol 50 % (v/v)  
EDTA 0.002 mM  
Bromophenol blue 0.0025 % (w/v)  
Xylene-Cyanol 0.0025 % (w/v) 
 
1x TAE buffer: 
 
EDTA 0.5 mM  
Tris-Acetat 40 mM  
 
10x TBE buffer: 
 
EDTA 10 mM  
Tris base 100 mM 
Boric acid 85 mM 
  
 
1x TE buffer: 
 
Tris, pH 7.4 10 mM 
EDTA 1 mM 
2.8 Databases and programs 
The human und murine genome sequence can be retrieved either via the ensembl browser 
(http://www.ensembl.org/), at UCSC genome bioinformatics (http://genome.ucsc.edu/) or at 
the National Center for Biology and Information (NCBI; 
http://www.ncbi.nlm.nih.gov/genome/guide/).  
 
MGI (http://www.informatics.jax.org/): 
MGI (mouse genome informatics) is the international database resource for the laboratory 
mouse, providing integrated genetic, genomic, and biological data to facilitate the study of 
human health and disease. The homepage contains information about genes, phenotypes, 
gene expression, functional annotations, biochemical pathways, marker polymorphism and 
information about orthology for mouse, human, rat, chimp, dog, and 12 other mammalian 
species. 
 
NCBI Homepage (http://www.ncbi.nlm.nih.gov/): 
The homepage of the NCBI offers numerous links to helpful databases and programs. The 
one used most in this work are given below: 
 
Human-Mouse Homology Map (http://www.ncbi.nlm.nih.gov/Homology/):  
This homology map opposes homologue chromosomal regions of human and mouse and 
provides the orthologous genes of these two species. 
 
NCBI (http://www.ncbi.nlm.nih.gov/genome/guide/M_musculus.html):  
All available data of the mouse genome sequencing project can be found at this webpage. 
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OMIM (http://www.ncbi.nlm.nih.gov/Omim/): 
The OMIM (Online Mendelian Inheritance of Man) database includes an index of human 
genes and genetic disorders. Additionally, detailed descriptions, figures and reference are 
provided. 
 
2.9 Mouse strains 
In this work the C57BL/6J and C3H/HeJ mouse strains and offspring from crosses of these 
strains were used for analyses. The preference of C57BL/6J mice for alcohol was one 
important selection criterion for these mice. According to behavioural studies, C3H/HeJ mice 
show differences in ethanol addiction-related behaviours compared to C57BL/6J mice. In 
particular they differ substantially in their preference for ethanol, which is a basic requirement 
for mapping ethanol-related traits (CRABBE et al. 2006b; ELMOR and GEORGE 1995; LI et al. 
2005). A caveat of the C3H/HeJ mice is the fact that they and all other Jackson sub-strains 
are homozygous for the retinal degeneration 1 mutation (Pde6brd1), which causes blindness 
by weaning age. The Pde6b (phosphodiesterase 6B) gene is located on mouse chromosome 
5 at 57.0 cM (MGI).  Furthermore, this strain is homozygous for an inversion on 
Chromosome 6 (symbol: In(6)1J) (AKESON et al. 2006). The inversion covers 20% of 
Chromosome 6, but it results in no reported phenotype. 
Parents of a mapping population must have sufficient variation for the traits of interest 
at both the DNA sequence and the phenotypic level, which is true for the parental strains 
selected here. In addition to that, C57BL/6J and C3H/HeJ mice meet the condition of a low 
degree of relationship, as they represent different branches of the family tree of laboratory 
mice (WITMER et al. 2003).  
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Figure 5. Mouse family tree. Mouse strains are organized into six major groups of branches. C57BL/6J 
mice belong to Group 3 of the family tree, C3H/HeJ mice to Group 1 (yellow boxes). The length and 
angles of the branches are optimized for printing and are not quantitative measures of evolutionary 
distance between strains. (Modified according to WITMER et al. 2003.) 
 
Genetic variation of the trait between the parents is important to reach the goal of finding 
genes contributing to a particular phenotype. If the parental mice differ to a great extend at 
the phenotypic level, there is reasonable chance that genetic variation exist. Moreover, the 
more DNA sequence variation exists, the easier it is to find polymorphic informative markers 
(LIU 1998).  
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3 METHODS 
 
3.1 Behavioural experiments 
All behavioural experiments were conducted at the in-house animal facility of the university’s 
clinical centre.  
 
3.1.1 Animals 
8-10 week old breeding animals were obtained from Janvier Laboratory (Janvier Breeding 
Center, France), which were mated to the second filial generation; first by crossing C57BL/6J 
x C3H/HeJ mice and subsequently by intercrossing the F1 generation. Eight to ten week old 
male and female mice were used in the studies. 
The S1 (Sicherheitsstufe 1, §§ 4-7 GenTSV) animal facility provided standardised 
climatic conditions where all animals were housed under reversed light-dark conditions 
(lights on at 7:00 p.m. and lights off at 9:00 a.m.). Animal care and experiments described in 
this work were approved by legal authorities (Landesamt für Natur, Umwelt und 
Verbraucherschutz NRW). All procedures were in compliance with national (Tierschutzgesetz 
v. 18.5.2006 (BGBl. I S. 1206, 1313), g v. 18.12.2007 (BGBl. I S. 3001; 2008, 47)) 
regulations and institutional guidelines. Cage allocation conformed the prescribed number of 
animals. Mice were housed individually if necessary for the respective experiment, otherwise 
in groups up to six animals. The animals had free access to food, drinking water or 
alternatively an ethanol solution when indicated by the experiment.  
 
3.1.2 Experimental design 
Behavioural assessments in F2 generation mice were performed in the following order: 1. 
Acute drug effect; 2. Forced ethanol drinking; 3. Withdrawal studies; 4. Ethanol preference; 
5. Stress-induced ethanol drinking (Figure 6). Every animal conducted the whole test battery, 
but some animals died during the course of the experiments and thus their number abated 
over time. The parental and F1 generations of mice were also examined in all paradigms, 
whereas the behaviours were not assessed in a consecutive sequence, but separately for 
each paradigm using different animals. Behavioural data of these two generations thus also 
provided information about the possible impact of the serial experimental setup used for the 
F2 generation mice. 
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Figure 6. Schedule of the behavioural experiments. Phenotyping began with the determination of 
acute hypothermia on postnatal day (pd) 56. All subsequent experiments were conducted during pd 64 
and 132 according to the order displayed in the scheme. 
 
3.1.3 Alcohol-induced hypothermia 
To determine acute alcohol effects and tolerance, parental and F1 animals received a single 
intraperitoneal (i.p.) injection of 1, 2 or 4 g/kg ethanol or saline (control). The animals’ body 
temperature was measured with a rectal thermometer immediately before and 30 minutes 
after ethanol treatment to monitor the physiological response in terms of temperature 
differences (hypothermia). In the F2 generation, all mice received an i.p. injection of 2 g/kg 
ethanol to assure comparability. This dose was chosen because the parental strains 
previously showed significant differences in hypothermia after chronic ethanol treatment, 
without exhibiting severe symptoms of toxication (up to death), as it was observed after 
administration of 4 g/kg ethanol. 
 
3.1.4 Chronic alcohol consumption and alcohol withdrawal 
Ethanol tolerance was evaluated three weeks after the beginning of forced ethanol drinking. 
For the forced drinking paradigm, animals were supplied with an ethanol solution as their 
only drinking source (Figure 7a). The ethanol concentration in the drinking water was initially 
low and then gradually increased, as displayed in Figure 6. As a result of this protocol, the 
mice were habituated to the ethanol taste and the development of a potential taste aversion 
was avoided. During the whole experiment, ethanol consumption (g/kg), food consumption 
(g/day), and the body weight of the mice (g) was recorded twice a week. Evaluation of 
ethanol-induced hypothermia after chronic ethanol consumption was performed in the same 
manner as the measurement for acute alcohol effects (see 3.1.3).  
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Changes in body temperature evaluated for acute and for chronic effects were compared to 
determine tolerance effects, whereby a reduction in temperature difference (reduced 
hypothermia) indicates the development of tolerance, an increase (increased hypothermia) is 
a sign of sensitization.  
 
 
Figure 7. Top view on a mouse cage during the forced drinking (a) and the two-bottle choice paradigm 
(b). 
 
For ethanol withdrawal studies, animals were maintained on a 16% ethanol solution for two 
more weeks to produce a state of somatic dependence. The ethanol solution was then 
replaced with tap water and withdrawal symptoms were determined using handling-induced 
convulsions (GOLDSTEIN and PAL 1971; WATSON et al. 1994). The procedure was performed 
3 hours after replacing ethanol with water by an experimenter, who was blind to the prior 
treatment. Each mouse was lifted carefully by the tail, held under a 60 Watt light bulb and 
was next gently rotated. The ensuing behaviour of the animals was scored for withdrawal 
symptoms according Table 2. 
 
Table 2. Evaluation scale of somatic withdrawal symptoms for handling-induced convulsions. 
 
Behaviour Score 
No behavioural change 0 
Mild tremor on lifting and turning 1 
Continuous severe tremor on lifting and turning 2 
Clonic forelimb extensor spasm on lifting 3 
Clonic forelimb extensor spasm on lifting, continuing 
after placing mouse on cage top 4 
 
To determine ethanol- and withdrawal-induced locomotor activity and anxiety the open field 
and the zero maze test were conducted. Testing was done during the forced drinking 
paradigm before and seventy-two hours after ethanol withdrawal.  
a b 
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Figure 9. Zero maze apparatus. 
Locomotor activity was measured in an infrared-beam-operated open field arena (45 x 45 x 
23 cm, ActiMot, TSE Systems; Figure 8) for 20 minutes.  
 
The open field box was kept in a soundproof 
enclosure. At the beginning of the test session, each 
mouse was placed in the centre of the testing 
chamber and subsequently the distance travelled (m) 
was recorded. Testing arenas were cleaned with a 
70% ethanol solution between subjects.  
 
 
 
Figure 8. Open field arena. 
 
The zero maze apparatus used for anxiety measurements consisted of an annular white 
platform (inner diameter of 46 cm, 5.6 cm width) elevated 40 cm above the ground level 
(Figure 9). It was divided into four equal quadrants, 
whereas non-transparent walls enclosed the two 
opposite quadrants. Each mouse was placed into the 
open area of the maze and the animals’ behaviour was 
videotaped using a camera fixed above the maze and 
analyzed with a video-tracking system (VideoMot; TSE 
Systems). Between subjects the apparatus was cleaned 
with a 70% ethanol solution. Distance travelled in the 
open parts of the maze in relation to the total distance 
(OD%) was evaluated as a parameter for anxiety. 
 
3.1.5 Alcohol preference 
Ethanol preference was measured via the two-bottle choice test, which followed the forced 
drinking paradigm. The animals had the free choice between two drinking bottles (with a 
metal ball in the sipper tubes to stop the dropping of fluids) (Figure 7b) during the whole 
experiment. One of these bottles contained an 8% v/v ethanol solution, while the other 
contained tap water. Bottle positions were changed daily to exclude the development of side 
preferences. The ratio of alcohol to total fluid consumption (%), the amount of consumed 
ethanol (g/kg), the body weight (g), and the food consumption (g) were determined twice a 
week.  
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3.1.6 Stress-induced alcohol drinking 
The influence of stress on ethanol preference and consumption was calculated with animals 
that had been in the two-bottle choice test since four weeks and thus exhibited a stable 
ethanol intake. The mice received a mild electric foot-shock through a grid floor located in a 
dark chamber (Startle Response, TSE Systems) with a continuous background white noise 
(65 dB). A warning signal (sound and light) was presented a few seconds before the shock. 
Five intermittent electric foot shocks (intensity, 0.5 mA; duration, 100 msec; interval between 
shocks, 55 - 60 sec) were delivered computerised through the grid floor. The chamber was 
cleaned with a 70% ethanol solution between subjects. The ratio of alcohol to total fluid 
consumption (%) and the amount of consumed ethanol (g/kg) was determined before (mean 
week 2-4) and 24 hours after the shock.  
 
3.1.7 Statistical data analysis of behavioural data 
All statistical analyses were performed using the STATISTICA software package. Acute 
ethanol effects and tolerance in the parental and F1 generation were evaluated using two-
way analysis of variance (ANOVA). To evaluate ethanol-induced hypothermia in naïve and 
ethanol-experienced mice, as well as for the comparison of acute and chronic ethanol effects 
(tolerance) in the F2 generation, a two-way repeated measures ANOVA was performed. 
Significance of ethanol withdrawal symptoms was calculated using a non-parametric Kruskal-
Wallis ANOVA. A two-way ANOVA was used to analyze locomotor activity and anxiety-levels 
in all generations. Ethanol preference and consumption, as well as stress-induced ethanol 
drinking in the parental mice, were evaluated using a three-way repeated measures ANOVA. 
Analyses of these parameters in F1 and F2 animals were achieved via a two-way repeated 
measures ANOVA. Overall, significant ANOVA were followed by a post hoc Tukey test for 
pair-wise comparison. A value of p < 0.05 was considered to represent a significant effect.  
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3.2 Biomolecular experiments 
The biomolecular experiments described in this work were conducted in laboratories of the 
Life & Brain Center at the university’s clinical centre. Statistical calculations for the QTL 
analysis were performed with the help of Professor Dr. Wienker and Dr. Diaz Lacava from 
the Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn.  
 
3.2.1 Mouse tissue preparation 
Liver tissue of all mice was removed for further analysis. Therefore, mice were sacrificed via 
cervical dislocation and the isolated organ was immediately shock-frozen in isopentan 
bedded on dry ice. Tissue samples were stored at -80°C.  
 
3.2.2 Isolation of genomic DNA 
Genomic DNA was isolated from frozen liver tissue. The isolation was conducted using the 
Qiagen DNeasy Blood & Tissue Kit (Qiagen) according to the manufacturer’s protocol. 
DNA concentration was evaluated photometrically at a wavelength of 260 nm using 
the FusionTM Universal Microplate Analyzer. For nucleic acid quantification, the Beer-Lambert 
(A = ε * b * c) equation is modified to use an extinction coefficient with units of M-1 cm-1. Using 
this extinction coefficient gives a manipulated equation:  
 
c = (A * ε) / b  
 
c: Nucleic acid concentration (ng/µl) 
A: Absorbance (absorbance units, AU)  
ε: Wavelength-dependent extinction coefficient (M-1 cm-1) 
b: Path length (cm) 
 
The generally accepted extinction coefficient for double-stranded DNA is 50 M-1 cm-1.  
 
Isolated and purified DNA was stored in a fridge at 4 °C until further use. Remaining tissue 
was kept at -80°C for long-term storage.  
 
3.2.3 Normalization of genomic DNA 
High-throughput DNA normalization was achieved using the liquid-handling platform 
Multiprobe II. Normalization was necessary to assure the use of equal DNA amounts for 
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subsequent polymerase chain reactions (PCR), a prerequisite for equal signal strengths on 
the genetic analyzer (see 3.2.5). All samples were normalized to a concentration of 3 ng/µl 
DNA. Normalized DNA was stored at 4 °C until further use.  
 
3.2.4 Selection of the microsatellite marker set 
The selection and design of the microsatellite markers used for genotyping was based on the 
dataset from the Whitehead Institute/MIT Center for Genome Research (WICGR). High 
marker polymorphism between the two parental strains and an equal distribution throughout 
the mouse genome were main criteria for selection. With the help of different mouse genome 
browsers (see 1.1), strain specific allele fragments lengths resulting from microsatellite 
amplification were compared to find microsatellites that were polymorphic between the 
parental mouse strains. The resulting markers were then selected for genome distribution, 
with a spacing of one marker each 5 cM. Thus, a dense microsatellite marker map was 
established to provide high-resolution QTL mapping.  
Microsatellites were amplified with primer sequences complementary to their flanking 
regions, whereas the required primer sequences were also taken from the MGI database. All 
primers used in this study were initially tested to confirm DNA amplification using PCR with 
DNA samples isolated from parental and offspring mouse liver. PCR products were primarily 
separated on agarose- and polyacrylamide gels. Agarose- and polyacrylamide gel 
electrophoreses were performed according to Sambrook and Russell (SAMBROOK and 
RUSSELL 2001). PCR conditions for all markers were finally adjusted according to the 
electrophoresis specifications of the genetic analyzer (see also 3.2.5). The resulting 
microsatellite marker set consisted of 264 markers that were spaced at a mean distance of 
5.5 cM throughout the mouse genome (Supplement table S1). DNA amplification resulted in 
PCR products with a length between 74 and 360 bp.  
 
3.2.5 Genotyping and fragment length analysis 
To determine the genetic constitution of F2 generation mice at a specific microsatellite locus 
genotyping of genomic DNA was performed via PCR. Subsequent analyses of the PCR 
products were done with a genetic analyzer, providing electrophoretic separation in a 
resolution up to one base pair lengths difference (Figure 10).  
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Figure 10. Workflow of DNA genotyping and fragment length analysis. (CA)n: Number of dinucleotide 
tandem repeats; C: Cytidine, A: Adenosine. See text below for details. 
 
3.2.5.1 Polymerase chain reaction  
Specific amplification of DNA fragments was achieved using PCR. The standardised PCR 
reaction and temperature profiles (Table 3 and Table 4) were specifically adjusted according 
to the thermodynamic properties of the oligonucleotide primer and the lengths of the 
amplified PCR products. Of great importance is the specific annealing temperature of the 
primer pairs with the DNA strands. To calculate the annealing temperature the following 
simplified formula can be used: 
 
TAnnealing = 2x nA+T + 4x nG+C [°C] 
nA+T: Number of A- and T- nucleotides 
nG+C: Number of G- and C- nucleotides 
 
Depending on the primer pair used for PCR either the HotStar Taq (Qiagen) or the NEB Taq 
was applied. PCR was carried out in 10 µl reactions. 
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Table 3. Standard PCR reaction (10 µl): 
 
Component Final concentration 
Genomic DNA 3 ng/µl 
Reverse primer 0.2 µM 
Forward primer 0.2 µM 
10x HotStar Taq buffer  1x 
MgCl2 2.25 mM 
dNTP mix 0.2 mM 
HotStar Taq polymerase 0.125 U 
Water (HPLC gradient grade) to 10 µl  
 
Table 4. Standard temperature profile: 
 
  
 
I Initial activation step 95 °C 15 min 
 
 
II Denaturation 94 °C 45 s 
35 cycles 
 
III Annealing 60 °C 45 s 
  
 
III Extension 72 °C 45 s 
 
 
IV Final extension 72 °C 10 min 
 
 
V Cooling 4 °C ∞ 
 
To efficiently genotype all F2 mice, a high-throughput PCR setup was established. Primer 
pairs were not multiplexed in one reaction batch, but were assembled according to their 
annealing temperature and the required Taq polymerase. Using 96-well microtiter plates, 96 
single PCR reactions could thus be conducted at once. Following PCR, products of different 
allele sizes and fluorescent dye labelling were pooled with up to four PCR products in one 
well of a microtiter plate. This way of sample handling allowed the integration of four 96-well 
plates into one 384-well plate, which was next loaded on a genetic analyzer. The high-
throughput PCR setup and associated sample processing was achieved by using the liquid-
handling platform Multiprobe II.  
3.2.5.2 Fragment lengths analysis 
To determine fragment lengths, PCR products were loaded on a ABI 3130xl Genetic 
Analyzer (supplied with the Data collection software®, Figure 11) and analysed with the ABI 
GeneMapper® software according to the manufacturer’s protocol. The genetic analyzer 
platform was provided with 16 capillaries with a length of 36 cm each. For internal DNA size 
standard, GeneScan™ 500 ROX™ Size Standard was used, which is a dye-labelled size 
 
} 
 
35 cycles 
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standard for the reproducible sizing of fragment analysis data. The standard contained 16 
ROX dye-labelled, single-stranded DNA fragments. As there is an internal DNA size standard 
in each capillary, the alleles could be sized accurately in base pairs. Alleles were visualised 
in a graphic format, with a peak representing an allele. 
 
 
Figure 11. ABI 3130xl Genetic Analyzer.  
 
Before capillary electrophoresis, PCR products were diluted with HPLC-purified water (1:2) 
and subsequently with deionised formamide (Applied Biosystems). This mixture was then 
denatured in a thermocycler at 96 °C for 5 minutes.  
 
Each sequencer reaction batch was composed as follows: 
 
Deionised formamide 9.7 µl  
ROX™ Size Standard 0.3 µl  
Each PCR product (diluted) 1 µl  
 
3.2.6 Detection and mapping of quantitative traits 
The probability of linkage between behaviour and marker is defined by the logarithm of the 
odds (LOD) score. The LOD score is a statistical estimate of whether two loci are likely to lie 
near each other on a chromosome and are therefore expected to be inherited together. The 
LOD score indicates the strength of evidence for the presence of a QTL, with larger LOD 
scores corresponding to greater evidence (BROMAN 2001). 
 
Mapping of QTL was done using the software package R/qtl (BROMAN et al. 2003), which is 
an extensible, interactive environment for mapping quantitative trait loci in experimental 
crosses. It is implemented as an add-on package for the freely available and widely used 
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statistical language/software R (R DEVELOPMENT CORE TEAM 2008). The core of R/qtl is a set 
of functions that make use of the hidden Markov model (HMM) technology to calculate QTL 
genotype probabilities, to simulate from the joint genotype distribution and to calculate the 
most likely sequence of underlying genotypes (all conditional on the observed marker data) 
(BROMAN et al. 2003). R/qtl also calculates several functions that are useful for a quality 
control of the input data used for mapping. Also these functions offer the possibility to 
scrutiny the reliability of the resulting outputs. The results provide information about the 
proportion of missing genotypes for each individual or each marker in the cross, about the 
recombination fractions (the proportion of meiotic products, which are non-parental – 
recombinant - at the loci) for all pairs of markers and the LOD scores for tests of linkage 
between pairs of markers. Furthermore, a genetic map of marker locations for all 
chromosomes is evaluated, which is then compared to that estimated with the observed 
data. This comparison gives information about the reliability of the observed genotype 
information: The more the marker locations differ between the two maps (which signifies 
variation in marker positions), the higher the possibility of genotyping errors.  
 
QTL mapping was done in several stages to identify loci acting individually and QTL that 
interacted, either additively or epistatically. To determine individually-acting QTL, a single-
QTL genome scan was conducted with the function scanone. For this function, R/qtl uses the 
maximum likelihood via the EM algorithm (LANDER and BOTSTEIN 1989), the Haley-Knott 
regression (HALEY and KNOTT 1992), or the multiple imputation method of Sen and Churchill 
(SEN and CHURCHILL 2001). In the present study, the multiple imputation (IMP) algorithm was 
chosen to substitute missing data points, albeit preliminary analyses using all three 
algorithms showed only minor differences between the results. Here, R/qtl uses the 
pseudomarker algorithm described by Sen and Churchill (SEN and CHURCHILL 2001). This 
algorithm simulates multiple versions of complete genotype information on a genome-wide 
grid of locations using information in the marker genotype data. Weights are assigned to the 
simulated genotypes to capture information in the phenotype data. The weighted complete 
genotypes are used to approximate quantities needed for statistical inference of QTL 
locations and effect sizes. 
As an additional tool, R/qtl provides the opportunity to calculate Bayesian credible 
intervals (confidence intervals) for a single-QTL on a particular chromosome. This interval 
was calculated with the function bayesint, whose output is a chromosomal interval in 
centimorgan (cM) that contains the QTL with a probability of 95%. Significance thresholds for 
single-QTL were based on 10.000 permutations.  
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For interacting QTL, a two-QTL genome scan was performed using the R/qtl function 
scantwo, again via the imputation method described above. Therefore, the maximum LOD 
score is calculated for every pair of position for the full model (lod.full; two QTL plus 
interaction) and for the additive model (lod.add; two QTL but no interaction). Furthermore, a 
LOD score for a test of epistasis (lod.int) is calculated by taking the difference between the 
maximum full LOD and the maximum additive LOD for each pair of chromosomes. Epistasis 
describes the phenotypic effect of interaction among alleles at multiple loci in addition to the 
direct effect of individual loci or, in other words, when the action of one gene is modified by 
one or several other genes. In a summary function, each pair of chromosomes is considered 
and the maximum LOD score for the full model and the maximum LOD score for the additive 
model is calculated, whereby these two models are allowed to be maximized at different 
positions. 
A significant lod.full in combination with a significant lod.int now indicates epistasis 
between the two respective chromosomal positions, whereby a significant lod.full in 
combination with a significant lod.add implies that the interaction of the two loci is additive. In 
the present study, the 5% permutation-derived significance threshold level based on 100 
permutations, giving significance levels for the full, the interaction and the additive LOD 
scores. In the results, genome-scan-adjusted p-values are given. To estimate the appropriate 
LOD threshold, the phenotype data are permuted, whereby the genotype data stay intact. 
Now interval mapping is performed and the maximum LOD score across the genome is 
identified. This process is repeated n times. The observed LOD score (with the phenotypes 
in the correct order) is compared to the n LOD scores obtained from permuted versions of 
the data. The proportion of these n LOD scores that exceed the actual, observed LOD score, 
is reported as an approximate p-value (BROMAN 2001).  
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4 RESULTS 
Mice of the parental, the first and the second filial generation were tested in paradigms 
modelling different aspects of alcohol addiction and related behaviours including alcohol-
induced hypothermia, alcohol tolerance, withdrawal-induced anxiety and locomotor effects, 
somatic withdrawal symptoms, alcohol preference and stress-induced changes in alcohol 
preference. Evaluation of behaviour in C57BL/6J and C3H/HeJ mice was conducted to give 
evidence for the different ethanol-related behaviour patterns in these mice. Subsequent 
quantitative trait mapping was conducted using the data obtained from pheno- and 
genotyping of the heterogeneous F2 mice. 
 
 
4.1 Behavioural analysis of the parental mouse strains  
The C57BL/6J and C3H/HeJ strains were selected, because they are genetically distinct and 
represent different branches of the family tree of laboratory mice (WITMER et al. 2003). In 
addition, it has been reported that they differ substantially in their preference for ethanol (LI et 
al. 2005). First, the behavioural and physiological responses to ethanol were characterized in 
these parental strains. 
 
4.1.1 Acute ethanol-induced hypothermia and tolerance 
Injection of ethanol to drug-naïve animals produced a dose-dependent reduction in body 
temperature in both parental strains, albeit with different response magnitudes, as revealed 
by significant main effects for strain (F1,61 = 20. 57, p < 0.0001), dose (F3,61 = 92.76, 
p < 0.0001) and strain x dose interaction (F3,61 = 9.52, p < 0.0001). Both strains showed a 
significant reduction in body temperature with a dose of 2 and 4 g/kg (p < 0.05). 
Administration of 4 g/kg ethanol produced a markedly stronger effect in C57BL/6J compared 
to C3H/HeJ mice (p < 0.05) (Figure 12a). A gender effect was not observed. 
To investigate the development of tolerance after chronic ethanol exposure, the 
animals were restricted to an ethanol solution (16%) as their only drinking source for a period 
of two weeks and subsequently ethanol-induced hypothermia was examined. A two-way 
ANOVA revealed again significant main effects for strain (F1,74 = 18.43, p < 0.0001), dose 
(F3,74 = 62.89, p < 0.0001) and strain x dose interaction (F3,74 = 7.56, p < 0.001). Both strains 
exhibited significantly enhanced hypothermia after administration of 2 and 4 g/kg ethanol 
compared to saline controls (p < 0.05), but again only the highest dose of ethanol resulted in 
a significant difference between the two strains (p < 0.05).  
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When comparing the results before and after chronic ethanol exposure, no significant 
interaction between the main factors strain, dose, and drug experience (F3,135 = 0.06, 
p = n.s.) was found. Thus, the parental strains did not develop tolerance to the hypothermic 
effects of ethanol (Figure 12b).  
 
 
Figure 12. Ethanol-induced hypothermia and tolerance. (a) Ethanol-naïve C57BL/6J and C3H/HeJ 
mice showed a significant reduction in body temperature after i.p. injection of 2 and 4 g/kg ethanol 
compared to saline controls. A significant strain difference was observed with a dose of 4 g/kg. 
C57BL/6J mice: saline, n = 5; 1 g/kg, n = 8; 2 g/kg, n = 8; 4 g/kg, n = 6. C3H/HeJ mice: saline, n = 11; 
1 g/kg, n = 5; 2 g/kg, n = 21; 4 g/kg, n = 5. (b) After two weeks of forced drinking, both strains still 
exhibited significantly enhanced hypothermia after administration of 2 and 4 g/kg ethanol compared to 
controls. Administration of 4 g/kg ethanol resulted in a significant difference between the two strains. 
The parental strains did not develop tolerance to the hypothermic effects of ethanol. C57BL/6J mice: 
saline, n = 5; 1 g/kg, n = 6; 2 g/kg, n = 6; 4 g/kg, n = 6. C3H/HeJ mice: saline, n = 11; 1 g/kg, n = 11; 2 
g/kg, n = 28; 4 g/kg, n = 12. Values represent mean ± SEM. Between strain comparison: 
### p < 0.001. Within strain comparison: *p < 0.05. 
 
4.1.2 Ethanol dependence and withdrawal 
The forced drinking paradigm was conducted to produce a state of somatic ethanol 
dependence in the mice (Figure 13a and b). During four weeks of testing the parental strains 
exhibited significantly different drinking behaviour (F1,53 = 11.28, p < 0.01). Also, there was a 
significant main effect for strain x gender interaction (F1,53 = 13.92, p < 0.001). A post hoc 
Tukey test for this interaction revealed that overall C3H/HeJ females differed significantly 
from C3H/HeJ male mice (p < 0.05). Within factor analysis revealed significant differences 
over the time course of the experiment (F3,159 = 5.71, p < 0.001) and a significant time x 
strain interaction (F3,159 = 9.84, p < 0.0001).  
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Figure 13. (a) Forced ethanol consumption. Comparison of mean ethanol consumption data revealed 
significant strain differences between C57BL/6J and C3H/HeJ mice. C57BL/6J males: n = 20; 
C57BL/6J females: n = 17; C3H/HeJ females: n = 9; C3H/HeJ males: n = 11. Values represent mean 
± SEM. 
 
After the forced drinking paradigm, withdrawal studies were performed. Handling-induced 
convulsions were evaluated three hours after replacing the ethanol solution with tap water. 
Mice of both parental strains exhibited significantly more tremors or forelimb extensor spasm 
after ethanol withdrawal and thus were physically dependent on ethanol (Kruskal-Wallis 
ANOVA, p < 0.001; Table 5).  
 
Table 5. Somatic ethanol withdrawal symptoms. Three hours after ethanol withdrawal the frequencies 
of high handling-induced convulsion (HIC score) were significantly increased in both strains. 
C57BL/6J: n = 160; C3H/HeJ: n = 61. 
   HIC score frequencies (%) 
   0 1 2 3 4 
C57BL/6J EtOH  42.5 56.3 1.3 0 0 
 Withdrawal  1.3 17.5 45.0 33.8 2.5 
C3H/HeJ EtOH  55.7 41.0 3.3 0 0 
 Withdrawal  4.9 32.8 32.8 21.3 8.2 
 
 
Locomotor activity was not changed, as mice of both strains were similarly active in the 
open-field arena before and after withdrawal (F1,62 = 0.22, p = n.s. for strain x withdrawal 
interaction; Figure 14a). Overall, C3H/HeJ mice travelled a significantly longer distance in 
this test (F1,62 = 6.48, p < 0.05).  
In the zero maze test there was evidence for higher anxiety-levels 72 hours after 
ethanol removal (F1,66 = 9.84, p < 0.01) (Figure 14b). C3H/HeJ mice were generally more 
active in the open area compared to C57BL/6J animals (F1,66 = 74.73, p < 0.0001) thus 
displaying lower anxiety-levels. A significant strain x withdrawal interaction was not found 
(F1,66 = 0.299, p = n.s.). 
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Figure 14. Open field and zero maze behaviour. (a) C57BL/6J and C3H/HeJ mice differed significantly 
in their open field locomotor activity. C57BL/6J: n = 41; C3H/HeJ: n = 25. (b) C3H/HeJ animals 
showed a higher locomotor activity in the open area of the maze than C57BL/6J mice. After withdrawal 
of ethanol, both strains showed a significant decrease in open area locomotion indicative of elevated 
anxiety levels. C57BL/6J: n = 41; C3H/HeJ: n = 29. Values represent mean ± SEM. Between strain 
comparison: # p < 0.05, ### p < 0.001.  
 
4.1.3 Ethanol preference and consumption 
Ethanol preference values were higher in C57BL/6J compared to C3H/HeJ mice (Figure 
15a). A three-way repeated measure ANOVA revealed a significant strain effect 
(F1,224 = 25.05, p < 0.0001) and a significant interaction between strain and gender 
(F1,224 = 24.58, p < 0.0001). Female C57BL/6J mice showed a higher preference for ethanol 
than males, while the opposite was true in the C3H/HeJ strain. Thus, gender effects seem to 
be strain specific. There was also a significant effect for the within factor time (F3,672 = 11.21, 
p < 0.0001), reflecting an increase in ethanol preference values during the course of the 
experiment.  
Similar results were obtained for the ethanol consumption data, since C57BL/6J and 
C3H/HeJ mice differed significantly in ethanol consumption (F1,328 = 58.68, p < 0.0001) 
(Figure 15b). Additional significant effects were found for gender (F1,328 = 5.41, p < 0.05) and 
for strain x gender interaction (F1,328 = 20.94, p < 0.0001). As for ethanol preference, 
significant differences for the within factors time (F3,984 = 11.15, p < 0.0001) as well as for 
time x strain interaction (F3,984 = 4.32, p < 0.01) was observed. There was no difference in the 
amount of consumed food, nor was there any difference in body weight. 
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Figure 15. Ethanol preference and consumption. (a) Ethanol preference was highest in female 
C57BL/6J mice and lowest in female C3H/HeJ mice. C57BL/6J males: n = 112; C57BL/6J females: n 
= 60; C3H/HeJ females: n = 26; C3H/HeJ males: n = 30. (b) Ethanol consumption values differed 
significantly between the two parental strains. C57BL/6J males: n = 192; C57BL/6J females: n = 84; 
C3H/HeJ females: n = 27; C3H/HeJ males: n = 29. Values represent mean ± SEM. 
 
4.1.4 Stress-induced ethanol drinking 
In order to evaluate changes in ethanol preference and consumption after stress exposure, 
the animals received a mild foot-shock after they had performed the two-bottle choice 
paradigm for four weeks. For ethanol preference, data analysis revealed significant effects 
for strain (F1,114 = 38.35, p < 0.0001), strain x gender interaction (F1,114 = 11.6, p < 0.001) and 
stress x strain x gender interaction (F1,114 = 5.13, p < 0.05). Generally, C3H/HeJ mice 
exhibited lower preference ratios before and after foot-shock compared to C57BL/6J mice.  
In C57BL/6J female mice there was no change in ethanol preference (p = n.s.), whereas in 
C57BL/6J male mice there was a significant increase in ethanol preference 24 hours after 
foot-shock (p < 0.05). In contrast, ethanol preference in C3H/HeJ mice did not change after 
foot-shock stress (p = n.s., Figure 16a). Overall, analysis of the ethanol consumption data 
revealed an increase in consumption after foot-shock (F1,114 = 4.30, p < 0.05). Furthermore, 
the two parental strains differed significantly in ethanol consumption (F1,114 = 41.48, 
p < 0.0001). Significant main effects were also detected for gender (F1,114 = 5.32, p < 0.05) 
and gender x strain interaction (F1,114 = 5.14, p < 0.001) (Figure 16b).  
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Figure 16. Stress-induced ethanol preference and consumption. (a) C3H/HeJ mice exhibited lower 
preference ratios before and after foot-shock compared to C57BL/6J mice. In C57BL/6J female mice 
there was no change in ethanol preference, whereas C57BL/6J male mice exhibited a significant 
higher ethanol preference after foot-shock. C57BL/6J males: n = 38; C57BL/6J females: n = 31; 
C3H/HeJ females: n = 25; C3H/HeJ males: n = 24. (b) Ethanol consumption was higher in C57BL/6J 
mice in stress-free and stressful conditions. An increase in ethanol consumption after foot-shock was 
observed in all mice except female C57BL/6J. C57BL/6J males: n = 39; C57BL/6J females: n = 31; 
C3H/HeJ females: n = 25; C3H/HeJ males: n = 23. Between strain comparison: # p < 0.05; 
### p < 0.001. Within strain comparison: **p < 0.01; ***p < 0.001. Values represent mean ± SEM. 
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4.2 Behavioural analysis of the first filial generation 
Breeding of C57BL/6J and C3H/HeJ mice led to a genetically homogeneous F1 generation, 
which was also phenotyped for ethanol-related behaviours.  
 
4.2.1 Acute ethanol effects and tolerance 
Drug-naïve mice of the F1 generation received an i.p. injection of three different doses of 
ethanol, which produced a similar dose – dependent reduction in body temperature as in the 
parental mice. Two-way ANOVA revealed a significant main effect for dose (F3,52 = 57.32, 
p < 0.001), but not for gender (F1,52 = 0.58, p = n.s.) or gender x dose interaction 
(F3,52 = 1.09, p = n.s.). A significant increase in hypothermia was seen after administration of 
2 and 4 g/kg ethanol (p < 0.001; Figure 17a). 
Chronic exposure to an ethanol solution (16%) again led to a dose – dependent hypothermic 
effect in F1 mice (F3,78 = 51.86, p < 0.0001 for factor dose; F1,78 = 0.41, p = n.s. for factor 
gender; F1,78 = 0.77, p = n.s. for dose x gender interaction). Still, there was a significant 
increase in hypothermia after administration of 2 and 4 g/kg ethanol compared to saline 
controls (p < 0.001) (Figure 17b). 
Three-way ANOVA did not reveal significant main effects for dose x gender x drug 
experience interaction (F3,130 = 1.57, p = n.s.). Thus, F1 mice did not develop tolerance to the 
hypothermic effects to ethanol. 
 
 
Figure 17. Ethanol-induced hypothermia and tolerance. (a) Administration of ethanol dose - 
dependently decreased the body temperature of female and male F1 mice, which was significant for 2 
and 4 g/kg ethanol compared to saline controls. Saline, n = 6; 1 g/kg, n = 8; 2 g/kg, n = 8; 4 g/kg, 
n = 8. (b) After chronic ethanol drinking, hypothermia was still significantly increased after injection of 2 
and 4 g/kg ethanol compared to saline controls, whereby no tolerance effect was observed. Females: 
Saline, n = 8; 1 g/kg, n = 9; 2 g/kg, n = 18; 4 g/kg, n = 9. Males: Saline, n = 7; 1 g/kg, n = 9; 2 g/kg, 
n = 18; 4 g/kg, n = 8. Values represent mean ± SEM. ***p < 0.001. 
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4.2.2 Ethanol dependence and withdrawal 
The forced drinking paradigm was used to monitor ethanol consumption in F1 animals 
(Figure 18). Female and male mice exhibited a significantly different drinking behaviour 
(F1,53 = 22.25, p < 0.0001), whereby females consumed higher amounts of ethanol. In both 
gender, the initial variation in ethanol consumption (F3,159 = 52.72, p < 0.0001) stabilized 
during the 4-week testing period. 
 
 
 
Withdrawal symptoms were evaluated three hours after replacing the ethanol solution with 
tap water as described for the parental strains. Mice of both gender exhibited significantly 
more withdrawal symptoms after ethanol removal as seen by increased tremors and stronger 
forelimb extensor spasm (p < 0.0001; Table 6).  
 
Table 6. Somatic ethanol withdrawal symptoms. Three hours after ethanol withdrawal the frequencies 
of high handling-induced convulsion (HIC score) were significantly increased in both gender. Females: 
n = 30; Males: n = 25. 
   HIC score frequencies (%) 
   0 1 2 3 4 
Female EtOH  23.3 53.3 23.3 0 0 
 Withdrawal  3.3 10.0 26.7 46.7 13.3 
Male EtOH  44.0 40.0 16.0 0 0 
 Withdrawal  8.0 16.0 20.0 48.0 0 
 
Withdrawal-induced changes in locomotor activity were not observed in the open field arena 
(F1,78 = 2.52, p = n.s.; Figure 19a), whereas in the zero maze mice of both gender covered 
significantly less distance in the open area 72 hours after ethanol withdrawal (F1,78 = 24.44, 
p < 0.0001 for withdrawal ; Figure 19b).  
 
Figure 18. Forced ethanol 
consumption. Female F1 mice 
consumed significantly higher 
amounts of ethanol compared to 
their male counterparts. After two 
weeks of testing, all mice 
displayed a stable alcohol intake. 
Females: n = 30; Males: n = 25. 
Values represent mean ± SEM. 
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Figure 19. Open field and zero maze behaviour. (a) Locomotor activity of F1 mice remained 
unchanged after ethanol withdrawal. (b) Overall, F1 mice showed significantly elevated anxiety levels 
after ethanol withdrawal, represented by the increase in distance travelled. Females: n = 23; Males: 
n = 20. Values represent mean ± SEM. 
 
4.2.3 Ethanol preference and consumption 
Ethanol preference and consumption were calculated in the two-bottle choice paradigm over 
a period of four weeks (Figure 20a and b, respectively). The preference values slightly varied 
over the course of the experiments (F3,132 = 3.07, p < 0.05). This effect was similar in both 
gender (F3,132 = 0.53, p = n.s for week x gender interaction). Analysis of the ethanol 
consumption data did not reveal a significant main effect in F1 animals (F1,51 = 2.42, p = n.s. 
for factor gender; F3,153 = 2.25, p = n.s. for factor week; F3,153 = 0.23, p = n.s. for gender x 
week interaction). F1 animals showed no difference in food consumption, nor were there any 
differences in body weight.  
 
 
Figure 20. Ethanol preference and consumption. (a) Ethanol preference ratio did not differ between 
male and female F1 animals, but it slightly varied over the experiment. Females: n = 25; Males: 
n = 21. (b) As for the preference values, ethanol consumption did not differ between females and 
males. Females: n = 29; Males: n = 24. Values represent mean ± SEM. 
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4.2.4 Stress-induced ethanol drinking 
Foot-shock stress did not provoke higher ethanol preference values in neither of the gender. 
Two-way repeated measure ANOVA revealed no significant main effects (F1,24 = 0.93, 
p = n.s. for factor gender; F1,24 = 0.21, p = n.s. for factor stress; F1,24 = 0.16, p = n.s. for 
gender x stress interaction; Figure 21a). In addition, no significant change in ethanol 
consumption was found, despite a tendency of higher alcohol intake after foot- shock stress 
in female mice (F1,51 = 2.23, p = n.s. for factor gender; F1,51 = 2.29, p = n.s. for factor stress; 
F1,51 = 0.67, p = n.s. for gender x stress interaction; Figure 21b).  
 
 
Figure 21. Stress-induced ethanol preference and consumption. (a) Ethanol preference was not 
affected by the foot-shock stress in neither of the gender. Females: n = 14; Males: n = 12. (b) The 
amount of consumed ethanol did not reach significance in the F1 mice. Females: n = 29; Males: 
n = 24. Values represent mean ± SEM.  
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4.3 Analysis of the second filial generation 
F2 generation mice obtained from the C57BL/6J x C3H/HeJ mice intercross were first 
phenotyped for several ethanol responses and subsequently genotyped to assess their 
genetic constitution at microsatellite loci throughout the mouse genome. QTL mapping was 
done via linkage analysis of the pheno- and genotyping data using two different approaches. 
Given below are the combined results for the F2 pheno- and genotyping.   
 
4.3.1 Data quality control 
In a first step the quality of input data was controlled to assure reliable mapping results. The 
current version of R/qtl (v2.7.2) includes functions for plotting marker distributions and 
estimating genetic maps. The final genetic map used in the present study consisted of 264 
microsatellite markers with an average marker distance of 5.56 cM, which represents high-
density whole genome coverage (Figure 22a). The side-by-side comparison of the genetic 
map obtained from databases to that estimated with the observed data revealed a minor shift 
in marker positions, as seen by the extended chromosome lengths in Figure 22b. Overall, 
this shift is tolerable, as marker positions can vary to a certain extend depending on differing 
experimental factors or different databases used to define the location of marker. In Figure 
22c, missing genotypes calculated from the input data are plotted. For each chromosome, 
individual mice are plotted vertically, the marker horizontally. Loss of genotype information in 
the present population lies within normal range. Nevertheless, the IMP algorithm was chosen 
for subsequent QTL mapping to substitute the missing data points (see 3.2.6 Detection and 
mapping of quantitative traits). As a last quality control tool, R/qtl provides the function of 
estimating recombination fractions, which gives information necessary for the construction of 
linkage maps. In Figure 22d, red-coloured pixels indicate a large LOD score or a small 
recombination fraction, while blue-coloured ones indicate the opposite.  
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Figure 22. (a) Marker locations on the genetic map used in the present study. (b) Side-by-side 
comparison of the genetic map obtained from the MGI database (left) to that estimated with the 
observed data (right). (c) Pattern of missing genotype data in the cross. Black pixels indicate missing 
genotypes. (d) Estimated recombination fractions and LOD scores for all pairs of markers (The 
recombination fractions are in the upper left triangle; LOD scores are in the lower right triangle). 
 
4.3.2 Mapping of quantitative traits 
In the followings sections, the results calculated with the function scanone are described, 
which maps QTL acting individually. Subsequently, possible QTL interaction (either additively 
or epistatically) was calculated using the function scantwo of R/qtl.  
 
 
a b 
c d 
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4.3.2.1 Acute ethanol-induced hypothermia and tolerance 
F2 animals received an i.p. injection of 2 g/kg ethanol to determine acute ethanol effects and 
ethanol tolerance. As shown in Figure 23a, administration of ethanol produced a reduction in 
body temperature that was similar in both gender (F1,550 = 2.21, p = n.s.). The single-QTL 
genome scan revealed one locus associated with this hypothermic effect on chromosome 1 
at 85 cM (Figure 23b). The 95 % confidence interval for this QTL covered the 81 to 87 cM 
region (Table 10). Additionally, the 10 cM position on chromosome 7 was associated with 
ethanol-induced hypothermia. In contrast to the parental strains, chronic exposure to an 
ethanol solution (16%) resulted in a reduced hypothermic effect of ethanol (F1,550 = 116.19, 
p < 0.0001). This result demonstrated that mice from the F2 generation developed tolerance 
after four weeks of forced ethanol drinking that was present in both gender (F1,550 = 1.17, 
p = n.s. for drug experience x gender interaction). After chronic ethanol exposure a 
completely different set of QTL was found on chromosomes 3, 6 and 13, with the highest 
LOD scores at 55 cM, 24.7 cM and 39 cM, respectively (Figure 23c).  
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Figure 23. Ethanol-induced hypothermia in naïve and ethanol-experienced mice. (a) Two weeks of 
ethanol drinking caused the development of ethanol tolerance in both female and male F2 mice, as 
indicated by the significantly reduced hypothermia after the second injection of 2 g/kg ethanol. 
Females: n = 280, males: n = 272. Values represent mean ± SEM, ***p < 0.0001. (b) A single-QTL 
genome scan revealed loci associated with the hypothermic effect on chromosome 1 and 7. (c) After 
chronic ethanol exposure we found QTL on chromosomes 3, 6 and 13. The horizontal line represents 
the threshold for significant LOD scores (p < 0.05). 
 
 
Possible interaction of chromosomal loci was analysed in a two-dimensional genome scan 
for the thermal response of the mice. To assess the nature of existing interaction, three 
different LOD scores are required. The LOD score for the full model indicates if there actually 
is any interaction, whereby the additive and the epistasis LOD score denote the type of the 
interaction - either additively or epistatically. In Figure 24, LOD scores for the full and either 
the additive model (a, b) or for epistasis (c, d) are plotted against each other for EtOH-
induced hypothermia in naïve mice. There was evidence for interaction between loci on 
chromosome 1 and several loci on other chromosomes (Figure 24a), with highest LOD 
scores and significant genome-scan-adjusted p-values for an interaction with chromosomes 
6, 7, and 8 (p < 0.05, Figure 24b). To evaluate the nature of interaction for EtOH-induced 
hypothermia in naïve mice, the epistasis LOD score has to be taken into account.  
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Figure 24. Results of the two-dimensional scan for hypothermia measurements in EtOH-naïve mice. In 
(a), LOD scores for a two-QTL model with interactions are plotted below the diagonal (full model), 
whereby LOD scores for the additive model are shown above the diagonal. In (c), the full model 
(below) is plotted against the model for epistasis (lod.int, above). Close-up of the two-dimensional 
scan on selected chromosomes for the full vs. either the additive (b) or the epistasis model (d). In the 
colour scale, the numbers to the right and left correspond to the values below and above the diagonal, 
respectively. 5% permutation derived threshold level based on 100 permutations. The tick marks 
correspond to the ends of the labelled chromosomes. 
 
As shown in Table 7, the scantwo - analysis revealed no significant epistasis LOD score for 
this trait (p > 1), but p-values for the additive LOD score were found to be significant 
(p < 0.01). These results indicated that the chromosomal interaction is of additive nature. 
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Table 7. Two-dimensional genome scan for EtOH-induced hypothermia in naïve mice. LOD scores, 
chromosomal positions and genome-scan-adjusted p-values for the full and the additive model as well 
as for the epistasis LOD score.  
 
Abbreviations: Chr.: Chromosome; Pos: chromosomal position in cM; p: p-value; lod.full/int/add = LOD 
score for the full, epistasis and additive model, respectively. * = Significant p-value. 
 
For EtOH-induced hypothermia in experienced mice (Figure 25), the two-dimensional 
genome scan at first suggested a possible interaction between loci on chromosome 3 and 13 
as well as between loci on chromosome 3 and 6, but after calculating 100 permutations this 
assumption failed, because the LOD score for the full model turned out to be not significant 
(genome-scan-adjusted p-value > 0.05).  
 
 
Trait
Chr.1 Chr.2 Pos1 (full) Pos2 (full) lod.full p (lod.full) lod.int p (lod.int) Pos1 (add) Pos2 (add) lod.add p (lod.add)
Ethanol-induced hypothermia in 
naive mice
1 6 85.0 20.68 10.98 0.02* 0.97 > 1 85 20.68 10.0 < 0.001*
1 7 85.0 4.50 11.35 0.01* 1.40 > 1 85 6.5 9.95 < 0.001*
1 8 85.0 8.0 10.39 0.03* 0.82 > 1 85 18.0 9.57 < 0.001*
Results  49 
 
Figure 25. Results of the two-dimensional scan for hypothermia measurements in experienced mice. 
LOD scores for a two-QTL model with interactions are plotted below the diagonal (full model). In (a), 
the full model is plotted against the additive model, in (c) against the difference of variance explained 
by the full model and the additive model (lod.int, epistasis). Close-up of the two-dimensional scan on 
selected chromosomes for the full vs. either the additive (b) or the epistasis model (d). In the colour 
scale, the numbers to the right and left correspond to the values below and above the diagonal, 
respectively. 5% permutation derived threshold level based on 100 permutations. The tick marks 
correspond to the ends of the labelled chromosomes. 
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The significant p-value for the additive LOD score does not denote an additive interaction, 
because the p-value for the full model, which calculates general interaction effects between 
two positions, did not exceed the significance threshold (Table 8).  
 
Table 8. Two-dimensional genome scan for EtOH-induced hypothermia in experienced mice. LOD 
scores, chromosomal positions and genome-scan-adjusted p-values for the full and the additive model 
as well as for the epistasis LOD score.  
 
Abbreviations: Chr.: Chromosome; Pos: chromosomal position in cM; p: p-value; lod.full/int/add = LOD 
score for the full, epistasis and additive model, respectively. * = Significant p-value. 
 
 
4.3.2.2 Ethanol withdrawal 
After ethanol removal, F2 mice exhibited significantly more tremors or forelimb extensor 
spasm during lifting and turning and thus received significantly higher withdrawal scores 
(Kruskal-Wallis ANOVA, p < 0.001; Table 9).  
 
Table 9. Somatic ethanol withdrawal symptoms. Frequencies of high handling-induced convulsion 
(HIC score) were significantly increased 3 hours after ethanol withdrawal. Females: n = 278; Males: 
n = 274. 
   HIC score frequencies (%) 
   0 1 2 3 4 
Female EtOH  41.1 37.3 18.6 3.0 0 
 Withdrawal  10.5 25.4 34.3 24.6 5.2 
Male EtOH  39.1 41.4 17.6 2.0 0 
 Withdrawal  10.1 25.9 27.5 25.9 10.5 
 
The single-QTL genome scan detected no significant QTL regions for the handling-induced 
convulsions as determined before ethanol withdrawal or after withdrawal (Figure 26a and b). 
Trait
Chr.1 Chr.2 Pos1 (full) Pos2 (full) lod.full p (lod.full) lod.int p (lod.int) Pos1 (add) Pos2 (add) lod.add p (lod.add)
Ethanol-induced hypothermia in 
experienced mice
3 13 54.6 43.0 10.26 0.08 2.38 > 1 50.6 41.0 7.88 0.03*
3 6 56.6 22.7 8.71 0.40 1.14 > 1 54.6 22.7 7.56 0.01*
6 13 22.7 39.0 9.32 0.26 1.16 > 1 22.7 39.0 8.16 < 0.01*
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Figure 26. Somatic ethanol withdrawal symptoms. During ethanol exposure (a) and after ethanol 
withdrawal (b) no significant single-QTL were identified. The horizontal line represents the threshold 
for significant LOD scores (p < 0.05). 
 
Ethanol withdrawal also caused a decrease in locomotor activity in the open field arena 
(F1,546 = 16.26, p < 0.0001) in male (F1,546 = 5.27, p < 0.05), but not in female mice (Figure 
27a). A highly significant QTL for the trait locomotion was found on chromosome 1 with a 
peak LOD score at 65 cM (Figure 27b). After ethanol withdrawal, the peak at 65 cM was also 
detected on chromosome 1. Additional QTL were identified on chromosome 7 (50 cM) and 
11 (43.1 cM) after withdrawal (Figure 27c). Due to the significant gender interaction, a QTL 
analysis was performed separately for each gender. The QTL found on chromosome 1 in the 
combined analysis was also seen in female and male mice before and after ethanol removal. 
For withdrawal-associated locomotion, a significant locus on chromosome 2 (1.4 cM) in male 
mice was detected. In females, a region on chromosome 11 (44.8 cM) was found to be 
significantly associated with this trait (Table 10). The QTL on chromosome 7 was no longer 
observed in the gender-specific analysis. 
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Figure 27. Open field. (a) Distance travelled in the open field arena was significantly reduced after 
ethanol removal in male animals. Females: n = 275, males: n = 273. Values represent mean ± SEM, 
*p < 0.05. (b) Under alcohol-drinking conditions, a highly significant QTL was found on chromosome 1 
at 65 cM. (c) After ethanol withdrawal, QTL were identified on chromosome 1 (65 cM), 7 (50. cM) and 
11 (43.1 cM). The horizontal line represents the threshold for significant LOD scores (p < 0.05). 
 
Ethanol withdrawal induced significantly more anxiety behaviour in the zero maze as 
displayed by a reduced activity in the open area of the maze (F1,545 = 513.49, p < 0.0001). 
This effect was observed in both gender (F1,545 = 0.05, p = n.s.; Figure 28a). Two positions 
on chromosome 5 were significantly associated with zero maze behaviour, whereas the more 
proximal section of the chromosome (42 cM) was related to the activity during ethanol 
exposure, the distal region (59 cM) to withdrawal-related zero maze behaviour. Furthermore, 
a QTL on chromosome 12 at 18 cM was found for ethanol-induced anxiety and at 21 cM for 
anxiety behaviour during withdrawal. Only after ethanol withdrawal a QTL on chromosome 1 
was identified, with a peak correlated region at 79 cM (Figure 28b and c). 
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Figure 28. Zero maze. (a) After ethanol withdrawal, mice covered a significantly shorter distance in the 
open area of the maze, indicative of elevated levels of anxiety. Females: n = 277, males: n = 270. 
Values represent mean ± SEM, ***p < 0.0005. (b) Two loci were significantly associated with ethanol-
induced anxiety, one on chromosome 5 (42 cM) the other on chromosome 12 (18 cM). (c) Under 
alcohol-free conditions a QTL on chromosome 1 (79 cM) and again a significant loci on chromosome 5 
(59 cM) and 12 (21) were found. The horizontal line represents the threshold for significant LOD 
scores (p < 0.05). 
 
4.3.2.3 Ethanol preference and consumption 
F2 animals displayed an overall lower preference for the ethanol solution than the parental 
strains (Figure 29a). In the two-bottle choice test, the preference values showed a slight but 
significant reduction during the four-week experiment (F3,1590 = 3.02, p < 0.05) in both gender 
(F1,530 = 1.16, p = n.s.). Measurement of ethanol consumption also revealed a significant 
decrease in consumption from week 1 to 4, which then slightly increased after the fourth 
week (F3,1605 = 7.78, p < 0.0001). Again no gender difference was found (F1,535 = 0.05, 
p = n.s.; Figure 29b). 
The QTL genome scan revealed a locus on chromosome 16 linked with the mean 
preference ratio (31.4 cM) and the mean ethanol consumption (19.4 cM), calculated as the 
mean values over the four-week experiment (Figure 29c and d).  
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Figure 29. Ethanol preference and consumption. Mice of both gender showed a similar ethanol 
preference (a) and consumption (b) over four weeks in the two-bottle choice test. Females: n = 267, 
males: n = 265. QTL genome scans revealed loci on chromosome 16 linked with the mean preference 
ratio at 31.4 cM (c) and the mean ethanol consumption at 19.4 cM (d). The horizontal line represents 
the threshold for significant LOD scores (p < 0.05). 
 
4.3.2.4 Stress-induced ethanol drinking 
Stress produced by a mild foot-shock resulted in an increased ethanol preference 
(F1,490 = 14.32, p < 0.001). Again this increase was similar in male and female F2 mice 
(F1,490 = 0.93, p = n.s) (Figure 30a). Before exposure to the foot-shock stress, the single-QTL 
genome scan revealed one region on chromosome 16 above the significance threshold 
(33 cM) (Figure 30c). After the stressor, however, no significant QTL was found for this trait.  
Ethanol consumption was also increased after foot-shock stress (F1,491 = 6.28, 
p < 0.05) in female mice, while males consumed similar amounts of ethanol (g/kg) before 
and after the foot-shock (F1,491 = 10.37, p < 0.01) (Figure 30b). A QTL for ethanol 
consumption before exposure to a foot-shock stress was mapped on chromosome 16 at 
29.4 cM (Figure 30d). After the shock, no significant association was found (Figure 30e, f). In 
a subsequent gender specific QTL scan we could not identify any significant QTL for the 
phenotype or the gender effect.  
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Figure 30. Stress-induced ethanol drinking. Mice of both gender exhibited a higher ethanol preference 
(a) and consumption (b) after the foot-shock. In contrast to their ethanol preference, female mice 
consumed significantly more ethanol (g/kg) before and after foot-shock compared to males. Females: 
n = 245, males: n = 247. Values represent mean ± SEM. *p < 0.05; **p < 0.001. (c, d) Before the foot-
shock stress, QTL genome scans revealed loci on chromosome 16 for both traits (33 and 29.4 cM). 
(e, f) After the shock, no significant association was found. The horizontal line represents the threshold 
for significant LOD scores (p < 0.05). 
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Table 10a. Position, p-values and LOD scores of all significant QTL revealed via single-QTL analysis 
combined for both gender.  
Trait All (n = 534) 95 % CI (cM) 
 Chr. Location (cM) p-value (LOD score)  
     EtOH-induced hypothermia 1 85  < 0.001 (6.6) 81 - 87 
 7 10 0.04 (3.6) 3.4 - 10.5 
EtOH-induced hypothermia in 
experienced mice 3 55 0.013 (4.1) 11.2 - 62.6 
 6 24.7 0.014 (4.1) 18.7 - 30.7 
 13 39 0.014 (4.1) 39 - 45 
     
EtOH -induced activity 1 65 < 0.001 (10.5) 63 - 71 
Withdrawal-induced activity 1 65 < 0.001 (10.3) 59 - 71 
 7 50 0.007 (4.4) 42.5 - 57.5 
 11 43.1 0.02 (4.1) 33 - 47.1 
     
Anxiety during EtOH exposure 5 42 < 0.001 (13.2) 39 - 64 
  12 18 < 0.001 (5.3) 13 - 22 
Withdrawal-induced anxiety 1 79 < 0.001 (6.5) 39 - 83 
  5 59 < 0.001 (15.0) 49 - 63 
  12 21 0.04 (3.6) 3 - 32 
     
Mean EtOH pref. (TBC) 16 31.4 0.009 (4.3) 17.4 - 35.4 
Mean EtOH cons. (TBC) 16 19.4 0.002 (5.1) 15.4 - 33.4 
      
EtOH pref. before shock 16 33 0.02 (4.1) 13.4 - 36.5 
      
EtOH cons. before shock 16 29.4 0.002 (4.8) 7.4 - 35.4 
      
Mean EtOH cons. (FD) 1 109 0.02 (3.9) 97 - 112 
  2 102 0.01 (4.3) 80.9 - 108 
  5 29 0.03 (3.9) 20 - 43 
  10 2 0.003 (5.0) 2 - 21 
  15 49 0.001 (5.2) 6.7 - 56.7 
      
 
Table 10b. Position, p-values and LOD scores of all significant QTL revealed via single-QTL analysis 
for female mice. 
Trait Female (n = 271) 95 % CI (cM) 
 Chr. Location (cM) p-value (LOD score)  
     EtOH-induced hypothermia in 
experienced mice 
6 26.7 0.014 (4.1) 20.5 - 74 
     
EtOH -induced activity 1 67 < 0.001 (7.0) 63 - 71 
Withdrawal-induced activity 1 51 0.001 (5.3) 29 - 71 
 11 44.8 0.002 (5.0) 35.1 - 45.1 
     
EtOH -induced anxiety 5 64 < 0.001 (6.3) 42 - 71 
Withdrawal-induced anxiety 1 64 0.015 (4.1) 41 - 80 
  5 51 < 0.001 (5.6) 45 - 67 
     
Mean EtOH cons. (FD) 2 92 0.003 (4.9) 79 - 99 
  10 2 0.048 (3.6) 2 - 66 
  15 32.7 0.028 (3.8) 6.7 - 52.7 
  2 92 0.003 (4.9) 79 - 99 
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Table 10c. Position, p-values and LOD scores of all significant QTL revealed via single-QTL analysis 
for male mice. 
 
Trait 
Male (n = 263) 95 % CI (cM) 
 Chr. Location (cM) p-value (LOD score)  
     EtOH-induced hypothermia 1 85 0.012 (4.2) 81 - 99 
EtOH-induced hypothermia in 
experienced mice 
1 85 0.04 (3.6) 75 - 91 
     
EtOH -induced activity 1 69 0.023 (3.9) 25.7 - 95.8 
Withdrawal-induced activity 1 69 < 0.001 (5.9) 57 - 79 
 2 1.4 0.011 (4.2) 1 - 5 
     
EtOH -induced anxiety 5 43 < 0.001 (8.9) 41 - 51 
Withdrawal-induced anxiety 5 57 < 0.001 (10.3) 45 - 64 
  12 13 0.023 (3.9) 1 - 23 
      
Chr: chromosome number. 95% CI: the R/qtl 95% confidence interval for the QTL (in cM). A p-
value < 0.05 represents significant effects. 
 
 
4.3.2.5 Summary of the two-dimensional-QTL analysis 
As described in detail for the hypothermia trait (see 4.3.2.1), a two-dimensional genome scan 
was also performed for all other alcohol-related traits using the function scantwo of R/qtl. 
Table 11 summarizes the results obtained from these analyses, presenting the significant 
interaction LOD scores and p-values for the respective phenotype.  
 
R/qtl did not calculate significant p-values for the ethanol-induced activity phenotype as well 
as for two parameters measured during the two-bottle choice procedure (mean ethanol 
preference, ethanol preference before shock; Table 11). For ethanol consumption after 
shock, the genome-scan-adjusted p-value was 0.06 and thus not significant. Nonetheless, 
the LOD score for the additive model reached the 5% permutation derived threshold, 
indicating that there likely exists additive interaction between two respective QTL. No 
epistatic interactions were detected for the primary loci with significant linkages, but we found 
chromosomal loci that might contain genes encoding for products that make additive 
contributions to the respective phenotype. 
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Table 11. Position, p-values and LOD scores of QTL revealed via two-dimensional QTL analysis 
combined for both gender. 
Abbreviations: Chr.: Chromosome; Pos: chromosomal position in cM; p: p-value; n.a.: not assessed; 
lod.full/int/add = LOD score for the full, epistasis and additive model, respectively. * = Significant p-
value, # = Significant LOD score. 
 
Noticeable are the results for the ethanol-induced activity phenotype, because there is strong 
evidence for an additive interaction of chromosome 1 with all other chromosomes. In the 
single-QTL analysis, only the QTL on chromosome 1 was detected, whereby no other 
chromosomal region reached significance. Overall, the two-dimensional genome scan 
revealed additive interaction between QTL that also act individually on the trait, but running 
the scantwo function also exposed interacting QTL that were not revealed by the single-QTL 
analysis. Furthermore, not all individually acting chromosomal regions were found to interact 
with each other in the expression of the respective trait.  
 
 
Trait Chr.1 Chr.2 Pos1 (full) Pos2 (full) lod.full p (lod.full) lod.int p (lod.int) Pos1 (add) Pos2 (add) lod.add p (lod.add)
Ethanol-induced activity 1 1 63.0 93.0 13.96 # n.a. 1.87 n.a. 63.0 99.0 12.1 # n.a.
1 2 63.0 103.0 14.21 # n.a. 1.52 n.a. 63.0 1.0 12.69 # n.a.
1 3 63.0 70.6 12.87 # n.a. 0.70 n.a. 63.0 46.6 12.17 # n.a.
1 4 63.0 64.0 13.66 # n.a. 2.26 n.a. 63.0 32.0 11.4 # n.a.
1 5 63.0 23.0 14.48 # n.a. 1.04 n.a. 63.0 23.0 13.44 # n.a.
1 6 63.0 46.68 13.59 # n.a. 2.05 n.a. 63.0 62.68 11.54 # n.a.
1 7 63.0 52.5 14.18 # n.a. 2.66 n.a. 63.0 8.5 11.52 # n.a.
1 8 63.0 50.0 16.40 # n.a. 4.10 n.a. 63.0 32.0 12.31 # n.a.
1 9 63.0 69.0 12.68 # n.a. 0.96 n.a. 63.0 23.0 11.72 # n.a.
1 10 63.0 70.0 14.27 # n.a. 1.28 n.a. 63.0 30.0 12.99 # n.a.
1 11 63.0 45.1 14.29 # n.a. 2.40 n.a. 63.0 45.1 11.9 # n.a.
1 12 63.0 3.0 13.05 # n.a. 0.85 n.a. 63.0 61.0 12.2 # n.a.
1 13 63.0 41.0 13.60 # n.a. 1.87 n.a. 63.0 59.0 11.73 # n.a.
1 14 63.0 35.5 14.16 # n.a. 2.10 n.a. 63.0 39.5 12.06 # n.a.
1 15 63.0 68.7 12.27 # n.a. 0.83 n.a. 63.0 68.7 11.45 # n.a.
1 16 63.0 7.4 13.63 # n.a. 1.13 n.a. 63.0 5.4 12.5 # n.a.
1 17 63.0 10.1 14.00 # n.a. 1.27 n.a. 63.0 8.1 12.73 # n.a.
1 18 63.0 56.0 12.29 # n.a. 0.87 n.a. 63.0 2.0 11.42 # n.a.
1 19 63.0 48.5 12.44 # n.a. 1.08 n.a. 63.0 50.5 11.36 # n.a.
1 X 63.0 57.5 14.98 # n.a. 2.29 n.a. 63.0 55.5 12.69 # n.a.
Withdrawal-induced activity 1 7 63.0 50.5 13.96 # < 0.001* 0.18 > 1 63.0 50.5 13.77 # < 0.001*
1 9 63.0 25.0 14.41 # < 0.001* 0.84 > 1 63.0 23.0 13.57 # < 0.001*
Anxiety during ethanol exposure 2 5 103.0 61 18.24 # < 0.001* 1,29 > 1 103.0 61.0 16.96 # < 0.001*
5 12 53.0 19 19.64 # < 0.001* 1,15 > 1 53.0 19.0 18.5 # < 0.001*
Withdrawal-induced anxiety 1 5 53.0 57.0 27.53 # < 0.001* 2.47 > 1 59.0 57.0 25.06 # < 0.001*
1 12 61.0 3.0 11.98 # < 0.001* 2.17 > 1 69.0 21.0 9.8 # < 0.001*
5 12 51.0 27.0 20.05 # < 0.001* 1.61 > 1 55.0 23.0 18.44 # < 0.001*
Two-Bottle Choice
Mean ethanol preference (%) 14 16 51.5 31.4 12.28 # n.a. 5.26 n.a. 51.5 29.4 7.02 # n.a.
Ethanol preference before shock (%) 6 16 32.68 31.4 10.43 # n.a. 3.43 n.a. 22.68 31.4 7.0 # n.a.
14 16 51.5 33.4 10.44 # n.a. 3.8 n.a. 51.5 31.4 6.64 # n.a.
Ethanol consumption after shock (g/kg) 19 19 22.5 24.5 68.23 0.06 17.01 0.9 22.5 24.5 51.22 # < 0.001*
Forced drinking
Mean ethanol consumption (g/kg) 1 15 103.0 52.7 10.26 # 0.01* 1.38 > 1 107.0 44.7 8.88 # < 0.001*
2 10 101.0 2.0 10.15 # 0.01* 0.48 > 1 101.0 2.0 9.67 # < 0.001*
2 15 103.0 44.7 10.07 # 0.02* 0.60 > 1 101.0 44.7 9.46 # < 0.001*
5 15 29.0 50.7 11.57 # < 0.001* 1.68 > 1 29.0 44.7 9.89 # < 0.001*
10 15 14.0 48.7 10.62 # < 0.001* 0.51 > 1 2.0 48.7 10.11 # < 0.001*
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5 DISCUSSION 
 
Many studies have shown that virtually all drug responses are under genetic control (CRABBE 
et al. 2006b), but the complex genetic nature of drug addiction has made it difficult to identify 
specific susceptibility genes. Here a consecutive analysis of behavioural and physiological 
responses to ethanol in combination with QTL mapping was used to investigate the complex 
genetic regulation of behaviours relevant to ethanol addiction in a mouse intercross 
population. Several genetic loci contributing to physiological and behavioural responses to 
ethanol were identified, including several novel chromosomal regions where no obvious 
candidate genes have yet been mapped. Some of these loci are specifically associated with 
responses in ethanol-experienced animals. Additionally, several QTL that have already been 
published were confirmed by the findings of the present study, thus validating the approach 
and supporting the significance of these loci on the development and manifestation of 
alcoholism.  
 
The parental and the F1 generations of mice were analyzed in a non-serial design, which 
means that unrelated behaviours were assessed in different groups of animals. These data 
showed that the parental strains differed significantly for most phenotypes and that F1 mice 
generally display intermediate phenotypes. 
 
5.1 Alcohol effects on body temperature regulation 
Acute alcohol intake exerts influence on several physiological responses, one of which is 
body temperature alteration. Being out in the cold, we tend to believe a "little sip" will help 
take away the chill - and it seems to work. The face flushes and the skin becomes warm, 
regardless of the temperature outside. However, these misleading signs of warmth hide the 
facts about drinking alcohol. While alcohol may make us feel hotter, it actually causes a 
decrease in core body temperature. In animal studies, low doses of alcohol have been 
demonstrated to increase release of nitric oxide and augment endothelium-mediated 
vasodilation (DENG and DEITRICH 2007). This state of an increased calibre of the vessels 
(vasodilatation) reflects an increase in surface area entailing temperature loss and increased 
blood flow (PUDDEY et al. 2001). Thus, the increasing blood flow into the skin, giving that 
warm feeling and making the face flush, induces a rapid decrease in body temperature, 
which in turn brings about an increased danger of hypothermia. Higher acute doses impair 
endothelium-dependent relaxation responses (MAYHAN and DIDION 1995). In contrast, 
chronic administration of alcohol to rats has generally been associated with tolerance to the 
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acute inhibitory effects of high-dosage alcohol on endothelium-mediated vasodilatation and 
may even result in augmentation of such responses (PUDDEY et al. 2001; SUN et al. 2008; 
WILLIAMS et al. 1990).  
Tolerance to the hypothermic effects induced by acute alcohol treatment (BROWMAN 
et al. 2000; COLLINS et al. 1996; CRABBE 1994; CRABBE and BELKNAP 1980; CRABBE et al. 
1982; RACZ et al. 2003) is partly due to enhanced metabolism and reduced CNS sensitivity 
(CHANDLER et al. 1998; COLLINS et al. 1996; DENG and DEITRICH 2007). Measurements of 
alterations in body temperature changes after chronic ethanol consumption therefore provide 
a useful tool to determine tolerance effects as an adaptive physiological response to 
prolonged alcohol exposure.  
 
In mice, administration of 2-4 g/kg ethanol at ambient temperatures results in a profound 
hypothermia in some mouse strains. Data of the present study revealed a dose-dependent 
reduction in body temperature with a maximum effect of approximately 5°C in C57BL/6J 
mice, compared to 3°C in C3H/HeJ mice, which is in good agreement with similar results 
from previous studies (BECKER and LOPEZ 2004; CRABBE et al. 2006a) and thus reflects the 
genetic contribution to this effect. Furthermore, these differences in body temperature 
changes demonstrate the phenotypic variation in ethanol tolerance within the two parental 
strains, on which this mapping study is based. Most mice develop tolerance to the 
hypothermic effects of ethanol after two weeks of forced ethanol drinking (CRABBE et al. 
2006a; CRABBE et al. 2006b). This was also the case in the F2 population mice, although 
some animals also exhibited sensitization to the hypothermic effects of ethanol. This 
demonstrates that opposite adaptive responses to chronic alcohol exposure can occur within 
the genetic spectrum represented in the intercross used here. 
To determine QTL acting on ethanol-induced hypothermia before and after chronic 
ethanol drinking, data obtained from the pheno- and genotyping of the heterogeneous F2 
generation mice were statistically linked using R/qtl. The locus with the highest linkage for 
acute responses was mapped to chromosome 1 at 85 cM. This finding is consistent with the 
Htas1 (hypothermia due to alcohol sensitivity) QTL (CRABBE et al. 1994b) that was linked to 
ethanol hypothermia after an i.p. injection of 3 g/kg ethanol (20% v/v in saline). This QTL 
contains the Prdx6 (peroxiredoxin 6) locus, which is associated with ethanol acceptance 
drinking and with amphetamine hypothermia (GOLDMAN et al. 1987), as well as with the 
severity of withdrawal from nitrous oxide (BELKNAP et al. 1993). Another potential candidate 
gene in this region is the TBX19 (T-box transcription factor, 86.6 cM), which regulates the 
expression of the proopiomelanocortin (POMC) gene and the terminal differentiation of the 
pituitary corticotroph lineage (PULICHINO et al. 2003). A recent genetic study showed that 
POMC is involved in ethanol addiction using knockout mice and human case-control 
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samples. Thus, ß-endorphin, which is derived from the POMC precursor protein, modulates 
ethanol consumption and dependence in animals and humans (RACZ et al. 2008).  
The other region that was linked to ethanol-induced hypothermia is located on 
chromosome 7 (10 cM). For this chromosome, only a QTL for ethanol preference is known 
(Ap7q at 25 cM). To date, no other alcoholism-related QTL within the confidence interval 
found here was mapped in mice so far.  
Overall, prolonged ethanol exposure in the forced drinking paradigm led to a reduced 
hypothermia. But in contrast to the mean values, the individual data of the F2 mice showed 
large variations. Some of the animals even exhibited a sensitization to ethanol, indicated by 
an increased hypothermia after chronic ethanol drinking. The distribution of individual values 
demonstrates the presence of informative outliers in the heterogeneous F2 population. For 
the hypothermic response QTL on chromosomes 3, 6 and 13 were found. On chromosomes 
6 and 13, two more Htas QTL were already described (Htas6 on chromosome 6 at 60 cM, 
Htas5 on chromosome 13 at 63 cM) (CRABBE et al. 1994b) and two interesting genes were 
linked to ethanol-related behaviours within these regions. One is the syntaxin binding protein 
3A gene (Stxbp3a) mapped to chromosome 3 F3 in the mouse genome. A variant of this 
gene, Stxbp1, is located on mouse chromosome 2 and was already identified as a candidate 
locus for ethanol preference (FEHR et al. 2005). Stxbp1 and Stxbp3a have syntaxin binding 
activity and are involved in glucose and protein transport. Both proteins have a Sec1-like 
protein domain, thus implying that the protein is involved in vesicle docking during exocytosis 
(MGI; http://www.informatics.jax.org/). Another interesting candidate gene is located at 41 cM 
within the QTL confidence interval on chromosome 13 - the DAT1 gene encoding for the 
dopamine transporter 1. Dopamine is one of the crucial neurotransmitter involved in drug 
reward. It was shown that administration of methamphetamine inhibits DAT transporter 
function and binding of DAT ligands, and that it produces a hyperthermic response 
(SANDOVAL et al. 2000). Furthermore, DAT expression influences thermal responses to 
psychostimulant drugs (JANOWSKY et al. 2001). After administration of ethanol, dopamine 
uptake by DAT in Xenopus oocytes is potentiated and transporter binding-sites are increased 
(RIHERD et al. 2008). The inclusion of the DAT1 gene within the QTL could point to the 
influence of dopamine in the development of tolerance after forced ethanol drinking and to a 
possible role of the dopamine transporter in the regulation of ethanol-induced hypothermia.  
Interestingly, the QTL on chromosome 1 and 7 did not influence hyperthermia after 
chronic ethanol exposure. Thus the acute ethanol effects on body temperature and the 
adaptive mechanisms after chronic ethanol exposure are regulated by different sets of 
genes. 
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The results obtained from the single-QTL analysis discussed above demonstrate the 
complex regulation of even an individual trait related to alcoholism. The two-dimensional 
genome scan conducted for the hypothermia phenotype revealed no epistatic interaction of 
the QTL described. Nevertheless, additive interactions of some of the QTL found for ethanol-
induced hypothermia in naïve mice demonstrate that three or more genes contribute to the 
trait in an additive or cumulative manner. The uncovering of genes that are involved in this 
interaction and their role in the genetic regulation of ethanol-induced hypothermia or the 
development of tolerance will be a task for future studies. 
 
5.2 Alcohol and anxiety 
Already 2000 years ago Hippocrates recommended drinking a mixture of wine and water as 
a remedy for anxiety (cited according to BAVING and OLBRICH 1996). Also the German 
neurologist Westphal, who first described the disease pattern of agoraphobia, named three 
ways to abate the phobia’s symptoms in his work in 1871: a close companion, a walking stick 
or the consumption of alcohol. Since then a number of publications described the comorbidity 
of anxiety and alcoholism in humans ((BAVING and OLBRICH 1996; BRADY and LYDIARD 1993; 
KUSHNER et al. 2000; SCHUCKIT and HESSELBROCK 1994), but also in animals (COOK et al. 
2002; KLIETHERMES et al. 2004; MOLLER et al. 1997). Typically, a prevalence of anxiety 
disorders in patients suffering from alcoholism or the incidence of alcohol misuse in 
individuals being under treatment because of anxiety disorders was found. Between 16% to 
25% of the patients suffering from anxiety disorders, alcohol-drinking problems were 
diagnosed (WOODRUFF et al. 1972). In patients treated for alcohol dependence, even 23 % to 
70 % exhibited dysfunctions in anxiety behaviour (MULLANEY and TRIPPETT 1979). Evidence 
for a causal relation of alcohol misuse and anxiety disorders was established by the 
examination of the temporary occurrence either diseases. The question is, whether the 
existence of an anxiety disorder abets the prevalence of alcohol dependence, or whether 
alcohol misuse can result in anxiety disorder development. Both hypotheses are currently 
discussed, whereby the former emanates from alcohol being a kind of self-medication for 
anxiety. The latter is based on findings showing adaptations in the nervous system after 
chronic alcohol use (see 1.2 Neurobiological effects of alcohol), which especially after 
ethanol withdrawal elicits anxiety states (BECKER and LOPEZ 2004; KLIETHERMES et al. 2004; 
RASMUSSEN et al. 2001). As already suggested by Kushner et al. (KUSHNER et al. 2000), the 
comorbidity between anxiety and alcoholism is possibly explained best by the consolidation 
of both hypotheses – namely the interaction of the anxiolytic and the anxiogenic effects of 
alcohol. Accordingly, short-term alcohol consumption causes anxiolysis, whereas long-term 
alcohol use contributes to the development of anxiety symptoms in terms of withdrawal-
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induced anxiety, which in turn can lead to relapse even after prolonged abstinence. 
 
5.2.1 Chronic alcohol consumption and withdrawal 
Overall, the C57BL/6J strain displayed significantly lower activity levels in the open field 
compared to C3H/HeJ mice, but showed higher anxiety-levels in the zero maze. The 
anxiogenic situation in a new environment (open field arena) possibly explains the downward 
trend in locomotion after withdrawal and thus rather reflects anxiety than locomotion. 
Increased anxiety levels after withdrawal as seen for both strains in the zero maze is a well-
known phenomenon that was previously shown by several studies (ABREU-VILLACA et al. 
2008; JASOVA et al. 2007; KLIETHERMES 2005; KLIETHERMES et al. 2004; SANTUCCI et al. 
2008; WILLS et al. 2008). The observed differences for anxiety measurements in the two 
strains are in line with other studies that also reported overall lower anxiety in C3H/HeJ 
compared to C57BL/6J mice (http://phenome.jax.org; (COOK et al. 2001; GRIEBEL et al. 
2000), and reflect the phenotypic diversity of the parental strains in this paradigm. In the F2 
mice, ethanol withdrawal caused a decrease in locomotor activity, an effect that was more 
profound in male mice. As expected and similar to the parental strains, the anxiety level after 
ethanol withdrawal was increased.  
The QTL with the highest linkage for distance travelled in the open field - in the 
presence or absence of ethanol - was found on chromosome 1. This locus is already known 
as an Activity-distance travelled QTL (Actd1, 65 cM) (GILL and BOYLE 2005b; KOYNER et al. 
2000), and thus the data presented here strengthen the evidence for this locus to play a role 
in locomotor behaviour. Several previous studies also demonstrated a location of an open 
field activity QTL on chromosome 1 (GERSHENFELD et al. 1997; KELLY et al. 2003; SINGER et 
al. 2005; TURRI et al. 2004), which indicates that there is more than one QTL for this trait on 
this chromosome (BOLIVAR et al. 2001; TURRI et al. 1999).  
Furthermore, preceding studies identified QTL on chromosome 1 that mediate the 
psychomotor stimulant response to ethanol. The QTL for activity response to ethanol (Actr1) 
is mapped to chromosome 1 with a peak correlated region at 85 cM (MGI, 
http://www.informatics.jax.org/). A study of Downing and colleagues (DOWNING et al. 2003) 
revealed a QTL influencing ethanol-induced locomotor activation on chromosome 1 at the 
88-100 cM interval. This region was also observed as a QTL mediating ethanol-activation 
(DEMAREST et al. 1999; HITZEMANN et al. 2000; HITZEMANN et al. 2002). Overall, several QTL 
have been localized in this region on chromosome 1 (83–102 cM) influencing behavioural 
and physiological responses to alcohol, which include alcohol preference, acute alcohol 
withdrawal, alcohol-induced hypothermia, sensitivity and tolerance to alcohol-induced ataxia 
and alcohol conditioned taste aversion (CRABBE et al. 1994b; GALLAHER et al. 1996; 
RISINGER and CUNNINGHAM 1998). The findings that QTL regions for open field activity and 
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for ethanol-induced activation are distinct from each other are consistent with the observation 
that these two traits are under an independent genetic control (DEMAREST et al. 1999; 
HITZEMANN et al. 2002). This conclusion also implies that the QTL on chromosome 1 
observed in the present study reflects the general locomotor activity of the mice rather than 
alcohol-related locomotion. This assumption is supported by the two-dimensional QTL 
analysis for open field behaviour, because the primary QTL on chromosome 1 seems to 
interact additively with loci on all other mouse chromosomes. This again may point to a gene 
lying within this QTL coding for a protein that is involved in multiple physiological circuits like 
it is the case for transcription factors or hub proteins, which are implicated in complex protein 
networks (HE and ZHANG 2006).  
After ethanol withdrawal, two QTL were found on chromosome 7 (50 cM) and 
chromosome 11 (43.1 cM) that were not detected for ethanol-induced activity. Furthermore, 
the examination of QTL-interaction showed an additive effect for the chromosome 7 and 
chromosome 1 QTL. As mentioned above, analysis of chromosome 7 revealed the ethanol 
preference QTL Ap7q (25 cM), but no other alcoholism-related mouse QTL. But, a locus for 
an activity phenotype alone was detected at 52 cM within the present confidence interval 
(TURRI et al. 2001a). Also noteworthy in this context is the Ofca2 (open field activity and 
conditioned avoidance 2) QTL mapped to 53 cM on chromosome 7 by Steinberger et al. 
(STEINBERGER et al. 2003). In the same study they also found an association with anxiety in 
the open field (entries into centre) at 54 cM on chromosome 7. This QTL may therefore 
reflect the alcohol withdrawal-induced anxiety in the open field.  
The QTL on chromosome 11, which only impacts on alcohol withdrawal-induced 
activity, also suggests a candidate locus in this region. Although there is the Alcw3 (alcohol 
withdrawal 3) QTL mapped to chromosome 11 (BERGESON et al. 2003; CRABBE et al. 1996), 
it is located at 18 cM and thus outside the present confidence interval.  
For zero maze behaviour a highly significant QTL on chromosome 5 was found, in 
both alcohol-drinking and alcohol-free conditions. This strong QTL additively interacts with all 
other primary QTL detected via the function scanone. A previously identified QTL for anxiety-
related behaviour lying within the confidence interval is Elmaz1 (elevated maze behaviour, 
57 cM). A second QTL for elevated maze behaviour, Elmaz2 (76 cM), is located outside this 
confidence interval (COHEN et al. 2001). Additionally in line with the QTL found on 
chromosome 12 (18 and 21 cM), an anxiety-related QTL has been mapped to this 
chromosome (Axtrb2, syntenic) (TURRI et al. 2001a). For withdrawal-induced anxiety 
behaviour a correlated locus on chromosome 1 (79 cM) was found. Since this QTL was 
completely absent before the withdrawal, this finding suggests the involvement of genes lying 
inside the confidence interval on chromosome 1 in alcohol-mediated anxiety. Because the 
confidence intervals for withdrawal-induced locomotor activity and withdrawal-induced 
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anxiety on chromosome 1 reflect different regions and are therewith genetically independent, 
a possible locomotor component in anxiety measures can be ruled out. A mouse QTL study 
looking for anxiety alone also discovered a chromosome 1 region without any drug treatment 
using the open-field test (TURRI et al. 2001b). In 2004, a QTL analysis verified a region 
spanning the 74-83 cM interval on chromosome 1 to be related to locomotor activity in the 
central (threatening) area of the open field. The authors suggested that the influence of the 
chromosome 1 QTL appears to be that of suppressing activity in most novel situations 
(HENDERSON et al. 2004). To date, two chromosome 1 QTL are known to influence anxious 
behaviour in mice and are annotated as Axtex (Anxiety-exploratory behaviour, syntenic) and 
Axtq1 (Anxiety QTL, 95 cM) (TURRI et al. 2001a; WILLIS-OWEN and FLINT 2006).  
Another possible explanation for the highly significant QTL on chromosome 5 in the 
present study may be the fact that C3H/HeJ mice and all other Jackson sub-strains are 
homozygous for the retinal degeneration 1 mutation (Pde6brd1), which causes blindness by 
weaning age. Two mutations have been identified for retinal degeneration 1 (rd1) mice. In all 
mouse strains with the rd1 phenotype a murine leukaemia virus (Xmv-28) insertion in reverse 
orientation in intron 1 is found. Further, a nonsense mutation (C to A transversion) in codon 
347 that truncates more than half of the predicted encoded protein has also been identified in 
all rd1 strains of mice. Despite the absence of rods, the mice exhibit normal 
photopotentiation (defined as a 50% augmentation in pupillary light response (PLR) 
compared to pre-bright light PLR during a one minute dim blue light exposure after bright 
light exposure). Although the entire outer retina of C3H/HeJ mice is destroyed, the inner 
retina remains intact (MGI Phenotypic Allele Detail, http://www.informatics.jax.org/). The 
Pde6brd1 mutation was mapped to chromosome 5 at 57 cM, a locus that lies within the QTL 
that was detected for zero maze behaviour in this study. Mice that are homozygous for this 
mutation are still able to differentiate between light and dark conditions and mice in general 
orientate mostly via their whiskers. However, it is certainly possible that the mutation 
contributed to the high LOD score in this QTL analysis.  
 
5.3 Alcohol preference and consumption 
The C57BL/6J mouse strain is known for its voluntary consumption of alcoholic solutions  
(CRABBE and BELKNAP 1980; TREADWELL 2006) and, unlike many other strains, C57BL/6J 
mice will readily drink ethanol solutions when they are presented together with tap-water. In 
contrast, it has been reported that female and male C3H/HeJ animals showed a much lower 
ethanol preference than C57BL6/J mice (LI et al. 2005). However, results of the two-bottle 
choice paradigm conducted in this study showed a significant difference between the two 
sexes. Female C57BL/6J mice showed a higher ethanol preference than male mice, whereas 
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the opposite was the case in the C3H/HeJ strain. Here, males displayed higher preferences 
ratios than females. Indeed, ethanol consumption of C3H/HeJ males was comparable to that 
of C57BL/6J male mice. In a study of Li et al. they demonstrated that F2 mice obtained from 
a C57BL/6J x C3H/HeJ intercross also revealed a sex difference with higher ethanol 
preference ratio in female mice compared to their male counterparts (LI et al. 2005). In the 
present study ethanol preference in the F2 population was determined at the end of the 
behavioural phenotyping after the forced drinking period. F2 animals now exhibited a 
significantly lower preference than the parental strains, and also showed no sex differences. 
It is noteworthy that the F2 mice in the present study exhibited a relatively low ethanol 
preference ratio of only 20%, which is comparable to the ethanol-naïve C3H/HeJ mice. One 
possible explanation for this finding may be the serial analysis approach used here. The mice 
are already alcohol-experienced after four weeks of forced ethanol drinking, which may have 
provoked an aversion for the ethanol solution. However this assumption is contrasted by 
results of an additional experiment conducted in our laboratory. Here, an individual group of 
F2 C57BL/6J x C3H/HeJ intercross mice displayed similar preference ratios in the two-bottle 
choice test, although they did not pass through the forced drinking paradigm before.  
Ethanol preference and consumption in the two-bottle choice test are often evaluated 
in parallel, and it is known that these traits are influenced by several genetic factors (SABA et 
al. 2006; VADASZ et al. 2000a). Analysis of the second-generation mice revealed an 
overlapping peak correlated region on chromosome 16 (preference: CI 17.4 – 35.4 cM; 
consumption: CI 15.4 – 33.4 cM) for these behaviours. This concordance indicates that this 
region acts on both ethanol preference and consumption and may reflect a common genetic 
control. The results of the two-dimensional genome scan support such a common genetic 
control, because the QTL on chromosome 16 interacts additively with chromosome 14 in 
both traits. Interestingly, Gill et al. found a suggestive QTL influencing ethanol preference in 
male recombinant inbred (RI) mice on this chromosome within the confidence interval we 
describe here (29 cM) (GILL and BOYLE 2005a). The dopamine receptor 3 (Drd3) gene maps 
in the interval (23.3 cM) of the QTL area that appears to be implicated in the motivation to 
self-administer drugs under schedules where the response requirements are high. The 
possible role of Drd3 in the control of responding by conditioned incentive stimuli remains 
unknown, but it has been shown that the Drd3 receptor density increases in the nucleus 
accumbens during conditioning. In several paradigms, the involvement of the Drd3 in drug 
reward has been confirmed by using Drd3-deficient mice. In contrast, reactivity to stimuli 
associated with natural reinforcers, such as food, appears unaffected by modulation of the 
receptor (BENINGER and BANASIKOWSKI 2008; LE FOLL et al. 2005). Another male specific 
alcohol preference locus (Alcp21) (GILL et al. 1998) was mapped to chromosome 16 at 45.6 
cM, thus about 10 cM distant from our QTL region. 
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5.4 Alcohol and stress 
Even older references than for the comorbidity of alcoholism and anxiety exist for the relation 
between alcoholism and stress. For example the Greek lyricist Alcaeus of Mytilene already 
stated 2500 years ago, that the best defence against grief of the mind would be drinking 
plenty of wine. Similarly, Shakespeare wrote in his play Julius Caesar (Act IV, Scene III): 
“Speak no more of her. Give me a bowl of wine. In this I bury all unkindness. . . .” (cited 
according to SAYETTE 1999). The idea of stress-relief by alcohol has led to many 
investigations in order to elucidate the mechanism(s) of interaction between stress and 
alcohol and of the stress-reducing effect of alcohol as a motivation for alcohol consumption. 
 Many different forms of stress (physiological and psychological) are believed to 
increase addiction vulnerability like e.g. deleterious effects of early life stress, child 
maltreatment, the experience of violence or work-related stressors (BRADY and SONNE 
1999). The exposure to such stressors can result in neuroendocrine, physiological, 
behavioural and subjective changes that are often long lasting and affect the corticostriatal-
limbic motivational-, learning-, and adaptation - systems including mesolimbic dopamine, 
glutamate, and GABA pathways. These adaptations represent the underlying 
pathophysiology associated with the stress-related risk of addiction (BREESE et al. 2005; 
SINHA 2008).  
Stress also increases the risk of mood and anxiety disorders that are highly comorbid 
with alcohol addiction. Accordingly, it is also important to examine whether there are specific 
stress-related factors that contribute to the development of mood and anxiety disorders or to 
addiction risk. Animal models of stress-induced increases in voluntary ethanol consumption 
provide a valuable mean to examine the (neuro-) biological principles of stress–alcohol 
interactions. For alcohol consumption, studies revealed increases (HILAKIVI-CLARKE and 
LISTER 1992; NUNEZ et al. 1999), decreases (VAN ERP and MICZEK 2001) as well as an 
unchanged intake (FIDLER and LOLORDO 1996) after stress. A deeper understanding of how 
stress may be responsible for drug abuse will likely have a significant impact on both 
prevention and treatment development in the field of alcohol addiction (SINHA 2001).  
 
F2 animals showed an increased preference ratio after foot shock, whereby mice with a 
lower preference exhibited a more pronounced increase in stress-induced ethanol drinking 
than mice with a higher preference. Although the QTL data of the study at hand imply a 
similar genetic regulation of ethanol preference and stress-induced ethanol preference, there 
are also studies from knockout mice that suggest the at least partially independent genetic 
regulation of these behaviours: Mice with a genetic mutation of the corticotropin-releasing 
hormone receptor 1 showed enhanced long-term ethanol preference after stress exposure 
(SILLABER et al. 2002), while cannabinoid receptor 1 knockout mice showed no effects of 
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stress on ethanol consumption, although the ethanol preference of both strains were either 
unchanged or only mildly affected by the mutations (RACZ et al. 2003; SILLABER et al. 2002; 
WANG et al. 2003). Such differing results once again stress the complex genetics underlying 
ethanol-related traits. 
Just under the significance threshold, a locus on chromosome 10 for stress-induced 
ethanol consumption was found. This locus at 17 cM lies within a syntenic QTL named Ssrq4 
(stress response QTL) specified by Thifault and colleagues (THIFAULT et al. 2008). The Ssrq4 
QTL showed significant linkage to thermogenesis during stress response and was identified 
in AcB RI strains (derived from A/J and C57BL/6J progenitors). Potential candidate genes for 
Ssrq4 include Cirbp (cold inducible RNA binding protein, 44 cM) and Igf1 (insulin-like growth 
factor 1.48 cM). Following GO (gene ontology) classification, Cirbp is localized in the 
nucleus, has RNA binding activity, and is involved in the response to stress. Another 
interesting result was revealed by the two-dimensional genome scan. Although not significant 
(p = 0.06), the data point towards additive QTL-QTL interaction between to different loci on 
chromosome 19. These QTL were completely absent in the single-QTL analysis, 
demonstrating that these QTL only act on the trait when occurring together.  
 
5.5 Somatic alcohol dependence 
The forced drinking paradigm was employed to produce a state of somatic ethanol 
dependence. For mice of the F2 generation, the amount of ethanol consumed during the 
procedure was linked to five chromosomal regions (chromosomes 1, 2, 5, 10 and 15) that all 
showed additive interaction in the two-dimensional analysis. In 2002, the Alcdp1 (alcohol 
dependency 1, 95.8 cM) QTL was mapped within the region of the confidence interval on 
chromosome 1 (BUCK et al. 2002). This locus was then confirmed by a study integrating 
functional genomics (gene expression) into the analysis strategy (HITZEMANN et al. 2004). In 
follow-up studies the authors finally identified promising candidate genes for loci on mouse 
chromosome 1 that affect alcohol physical dependence (DENMARK and BUCK 2008). 
Additionally, these QTL were shown to be syntenic with human chromosome 1q23.2-23.3 
(KOZELL et al. 2008).  
Several previous studies also showed that loci on chromosome 2 act on ethanol 
preference and consumption, which has been annotated as Etohc1 (ethanol consumption, 
28.0 cM) (BELKNAP et al. 2001; FEHR et al. 2005; PHILLIPS et al. 1998; SABA et al. 2006). In 
the present study, the QTL for the ethanol consumption phenotype was mapped at 102 cM 
on chromosome 2, which is consistent with findings of Vadasz et al. (VADASZ et al. 2000b) 
using Recombinant QTL Introgression (RQI) strains. Analysis of their data indicated QTL with 
largest effects on alcohol consumption at 105 and 107 cM on chromosome 2. This QTL is in 
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close proximity to the gene coding for the α4 nicotinic acetylcholine (nACh) receptor subunit 
(108 cM). It has been shown that alcohol exposure is able to increase mRNA levels for the 
α4 subunit in M10, in SH-SY5Y neuroblastoma and in PC12 cells (DOHRMAN and REITER 
2003; GORBOUNOVA et al. 1998). In 2001, the association between a functional 
polymorphism in the α4 nACh receptor subunit and alcohol consumption was confirmed 
(TRITTO et al. 2001). Also interesting is the proximity of our peak correlated region to the Oprl 
(opioid receptor – like, 110 cM) gene, coding for a receptor that is activated by 
nociceptin/orphanin FQ (CHIOU et al. 2007; PAN et al. 1996). As already mentioned above, 
there is significant experimental evidence implicating the endogenous opioid system in the 
processes of reward and reinforcement. Also in line with the results at hand, a study with 
AXB / BXA RI strains showed significant association between a marker at 107 cM (D2Mit74) 
and alcohol preference in both gender (GILL et al. 1996).  
The QTL on chromosome 10 (2 cM) identified in this study is in close proximity to a 
QTL for ethanol preference identified by Gill et al. (at 4 cM). Interestingly, the mu opioid 
receptor gene (Oprm), which has been implicated in ethanol preference, maps to 8 cM on 
chromosome 10. The 6 cM distance between the mapping result here and the location of 
Opmr is within the resolution of the analysis. 
There are two affirmed QTL close to the highest peak that was found on chromosome 
15, which may be of relevance for alcoholism: The Drb7 (dopamine receptor binding 7, 45 
cM) and the Lore5 (ethanol loss of righting reflex, 46 cM) QTL (MGI, 
http://www.informatics.jax.org/). Several overlapping regions on chromosome 15 were 
identified as QTL acting on ethanol consumption in previous studies (GEHLE and ERWIN 
1998; PHILLIPS et al. 1998; TARANTINO et al. 1998; VADASZ et al. 2000a; VADASZ et al. 
2000b). 
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6 SUMMARY AND OUTLOOK 
The genotype-phenotype analysis presented here identified a number of novel QTL linked to 
a variety of physiological and behavioural responses to alcohol, and confirmed several 
previously identified ones. These findings demonstrate that the genetic analysis of alcohol 
responses evaluated in single endpoint analyses used in most pervious studies and the 
serial analysis protocol used here leads to convergent results. Thus, although one 
behavioural test can often influence the outcome of another test performed with the same 
animal, the genetic control of ethanol responses seems to be sufficiently robust to permit 
significant modifications to the experimental protocol. The present study clearly 
demonstrates independent genetic control of different physiological and behavioural 
responses to alcohol that are relevant for addiction using a broad spectrum of phenotypic 
information. The different traits observed in alcoholic patients and in animal models of 
alcoholism are obviously linked to numerous chromosomal regions and thus the findings 
stress the importance of examining the whole entity of a complex disease to identify its 
genetic basis. This study also provides first data showing interaction patterns between 
alcohol-related traits. Since all loci interactions found for primary QTL were of additive 
nature, the results underscore the conclusion made from the single-QTL analyses, namely 
that of an independent genetic control of alcohol responses. Obviously, no epistasis exists 
between the candidate loci presented here.  
 
The knowledge of alcoholism-related chromosomal loci gained within the scope of this thesis 
provides the basis for subsequent experiments aiming at the identification of specific 
candidate genes that are involved in the genetic regulation of alcoholism and its related 
characteristics. The comprehensive comparison with existing literature and databases will be 
extended, also including findings from human studies, to further narrow down the QTL 
regions and thus the number of possible candidate genes. Fine mapping studies using single 
nucleotide polymorphisms (SNPs) are one option to follow up the present studies. Interesting 
findings will be validated using transgenic and/or knockout animals to elucidate the function 
of the respective gene. Brain tissues from the behaviourally and genetically well-
characterized and diverse animals presented here have also been archived and will be an 
important resource for the downstream analysis of candidate genes for drug addiction. 
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Marker name Forward primer Reverse primer 5' - Label C57BL/6J C3H/HeJ 
D1Mit64 AGTGCATTATGAAGCCCCAC TCAAATTTTAAAACAACCCATTTG FAM 126 121
D1Mit430 TATTAATGTTGAAGCCAGAAGCC CTTTAATCATCTCTGTGGCAAGG HEX 121 131
D1Mit169 CGCTGACTGCTACTTTATTATATTCC TCTGATTTACTGTCAATCAAGAGACC TET 150 156
D1Mit245 TGGTTACACAAGTCCAATACCG GGCCCAGGTCTATAAATAAGCC FAM 151 163
D1Mit236 ATACCCACCTAGCCTTTGTATAGG GGAAGAAGGCTCAGCAAGTG HEX 150 143
D1Mit161 ACCAGCCCTCCTTTTTTGTT CTTGCCTCTTCAGGCACCT TET 121 123
D1Mit303 GGTTTCTATTTCGGTTCTCGG TCTGTGCTGCAAAACAGAGG FAM 131 125
D1Mit251 TCTGTCCTTTCTGATGATTACTTCA ATGGTGAAATATCACATGGCA HEX 195 207
D1Mit132 TATTGTTTATGGAAATTGGACCC CATCTCTGAAGGAAAAAGTGCA TET 155 169
D1Mit215 GAGCAGAGTGTGAGAAGGG CCAGTGTGAGCCCATTCC FAM 156 164
D1Mit149 AAAGAGAATCTGACTTACCCATGG TGTGAGGGAGAAGAATTATGTCTG HEX 135 129
D1Mit135 TTGATGACTTAAAAATGTCAATACTGA ACACCCCTGCCTTAAAATATTT TET 184 174
D1Mit94 CGACTTCCCTTGATGTCCAT TTTGTGTTGTGCAGTCTGTCTG FAM 163 223
D1Mit139 CGACATTATCACTTCAGAGTTTGA GAGTTCCAGCCCACTGAGAG HEX 249 237
D1Mit446 TGAGTATATCATGAAGACAGCAACC ACGTATTTACCTTGTTCTGAATTTTG TET 175 141
D1Mit538 CCCCAACTTGGTCATGATGT CCTCAGAGGAGGTAGGTGAGG FAM 149 147
D1Mit200 GCCATGTTCATGTACATAGGTAGG ATGGATGGATGGTTTTCCTG HEX 212 304
D1Mit399 TTAGGGTATGGGAAGGGGAG TCATTTCCCAGTCATTGTGTG TET 145 142
D1Mit353 TACACTATGGGTATATGCTCACTATGC ACACATGAACATACTCATATGCACA FAM 125 109
D1Mit206 TGAGGCACCTTTGTATTCAGC CCAGATGTCTTTGAACATTCTCC HEX 130 125
D1Mit221 GGATTGCTATAACAGGAGCAGG ATGGCAGAAGATGGATGAGG TET 139 128
D1Mit292 GAACTGGAGGTTTGCTACTGC GGACATTGTTATCTCAGTTTTCTTC FAM 208 205
D1Mit155 ATGCATGCATGCACACGT ACCGTGAAATGTTCACCCAT HEX 259 223
D2Mit1 CTTTTTCGTATGTGGTGGGG AACATTGGGCCTCTATGCAC TET 131 127
D2Mit117 CCCAAAGAACATACATCAATGTG TGGAGATGCATGTTTAAAACTCA FAM 181 177
D2Mit365 GAGATCCCACTGATGATACAAGC AGATGTGCCCAAGGGTCC HEX 109 113
D2Mit369 GCCTCCATCAAAGGAAGACA TTTCTTCCCTGTCTATGTGATAAGG TET 136 117
D2Mit458 GTAGTTGAGGAAGACAATTGACACA AGTGCTGTCCTCTGGGCTTA FAM 129 105
D2Mit90 TCTTTTGTAAAGATTTGTTTCGTG  TATGTCTAGGGTGTCCGATGC HEX 93 107
D2Mit92 TGTATGCACAGGTATTTCCCC TGAGGAAAGGGGATAAAATTTG TET 155 117
D2Mit37 TGTGCAAGCCAGAAAAGTTG  GAAGGGGATTGTAAATTGGTACC FAM 181 187
D2Mit100 GTGTTCCTAAGGTTGTATTTTGGC GAAATTTGACAATTGCTAGGTGC HEX 121 133
D2Mit101 ATAATTCCTGATTTGCTGTTTGTG ACATGAAGCCTAGAGGGTGC TET 199 227
D2Mit398 GTACCTCTGGCTCCTGAGG TATTTTAAAAGTATAGGTGTGTGCCG FAM 153 139
D2Mit305 CTCAGAAAACATGCAATTGAGG ATGAGTGCAAACCAAATAAAATTG HEX 144 108
D2Mit395 AGGTCAGCCTGGACTATATGG AGCATCCATGGGATAATGGT TET 135 129
D2Mit164 TCTCTGCTAATTAAGTTGAAGAGTGC ACCAGTGTGTGTTTGTATGATGTG FAM 148 120
D2Mit208 CAAAAAGCCACAGCCACC GTTTATAATCAAGAGGCTATCTTGGG HEX 115 195
D2Mit498 GCAGCCTTTCCTTCCTTTCT CAGATAGAGCACTCAGACATACATACA TET 129 121
D2Mit285 TCAATCCCTGTCTGTGGTAGG TATGACACTTACAAGGTTTTTGGTG FAM 145 155
D2Mit263 ACTGAATCATCTCTCTCCTCAGC AGTTCAGTTCTTAGAACCCACAGC HEX 147 141
D2Mit226 TTTTTGCAACTTTGTTAAGAATTCC AAAACACCCTCCCACCCTT TET 109 131
D2Mit147 CATCCCTAAGACAAGCAACTCC GTCACAATGTCCTTCTCCATCA FAM 124 128
D2Mit457 GACTTTCACATGAAAGTTGTTAGACC TAGTGATTGCACTTAATTGTATGCC HEX 127 121
D3Mit130 AACACATGAAACGTGTGCGT TGATAGGCATGCTTAAGCCC TET 156 128
D3Mit92 CCTCTGTTAGGATATCCAATCCC CTTGTGTCCCTCCACTTGGT FAM 249 245
D3Mit203 CTGAATCCTTATGTCCACTGAGG GGGCACCTGCATTCATGT HEX 161 145
D3Mit179 TTTCCACAGGGAACCATACTT AACACACTACCTATGTTTTCTTTCTCT TET 157 134
D3Mit354 ACTCGAGATTCCTCTCAA CTAGGAAAGAAAGCTATTGCAT FAM 367 312
D3Mit333 CTCCCTCCCTTCCTCCTTC ACAAAAGCAGAAGACTGATCCC HEX 133 151
D3Mit67 AGCATACATCATAGCCTAAAATGG GTAACTAGGGAGACAGCCACTTG TET 153 151
D3Mit199 CCAGACCTCAGAAAGTGAGTCC ACCATGACATTCATGCTATTGTG FAM 148 121
D3Mit339 TCTATATTTGGGGGGAAGGG GATTTAGTGTCAAAGGCTATGCA HEX 155 125
D3Mit74 TCATCGTAGCAATAGAAATCCTG CACCGTTTCCTGACCTCTGT TET 159 155
D3Mit101 CCTCTAGATGCATACATGTGCC GGTCAAGTTAAGTGTATTTTTTTCCC FAM 115 133
D3Mit57 TCCAGTTACTTGGTGAACTCCA ATATGTGTACATGTTCATGGTGTG HEX 165 163
D3Mit216 AGGACTGAAGAAACATACACATGC AGAAACATCTTGATTTTCAACAAGG TET 129 149
D3Mit14 ATTGCGGTTAAAGTTTGCTT TCCTGCAAATTGTCCTCTGA FAM 177 205
D3Mit257 CCTAGCGCAGGAATAGTTAACC ACAAACAGAACAAAACAAAAAGTCC HEX 135 227
Expected fragment lengths
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Marker name Forward primer Reverse primer 5' - Label C57BL/6J C3H/HeJ 
D3Mit18 GAACAGTTCCCAGGTCCTCA CTGCCTTTAAATTCTGTCACCC TET 238 219
D3Mit262 TTGTGTTTTTTATTGTTTGTTTTGG GAGGTAGAGAAATCTGACAGAGCC FAM 142 146
D3Mit116 TCACTGCCCATCTTTGTAACC CCCAGAGACCCGGAATAGAA HEX 270 282
D3Mit19 CAGCCAGAGAGGAGCTGTCT GAACATTGGGGTGTTTGCTT TET 167 183
D4Mit149 TGAATTCAGAAGGATGTGTGTATG ATGTGAGAATCAACACCTGAGG FAM 121 137
D4Mit50 AAGGCAGAAACACAAAAATACATG TGATGGTGTTCCATATGTCTTATG HEX 103 109
D4Mit39 TCTTTTCTGCCCTCACAGCT GTCTATCTTGCCAATTTCAGGG TET 179 175
D4Mit286 ATGGGGTCTAGGAAAACATGG AAATTATGAGTATTTCACCTGAGTGTG FAM 103 83
D4Mit89 GTGGGCATTTTTTTTGTGGA TTCCCAGATCCTCTCCCTCT HEX 139 125
D4Mit139 CAGCCGTAGAAGAGAAGTAATTTT ATCAAACTGGGAAGAGCCAA TET 159 151
D4Mit87 ACAGGTAGGAATGGAGCCCT TCATCCCTTTGCCAAAGC FAM 123 127
D4Mit178 GCCCTGAAGGTAAATCAGTAACT GCTCAGGAGGTACATTGCCT HEX 153 177
D4Mit27 GCACGGTAGTTTTTCCAGGA TGGTGGGCAGGCAATAGT TET 157 125
D4Mit153 ATATGGAGTCTGTGTGTGTGTGC CACTGAATTTCTATTGTTGGAATAGG FAM 129 119
D4Mit31  ACGAGTTGTCCTCTGATCAACA AGCCAGAGCAAACACCAACT HEX 129 119
D4Mit76 TGAAGGAACCTGAAGCAAGG ACCTCCCAGGAGTGTCCAG TET 189 179
D4Mit203 GAATTCTTCCTGGGCCTTTC CAAGAGCCCAGGTGTGGTAT FAM 151 131
D4Mit251 AAAAATCGTTCTTTGACTTCTACATG TTTAAAAGGGTTTCTTTATCCTGTG HEX 123 135
D4Mit32 CCCTGGATAAACGTCATTTAATTC ATGGTTGGGTGTTACCAGGA TET 155 191
D4Mit233 TGGTCATGTGTGTCCATGC ACTTCATGTAGCCAGGTGGG FAM 184 174
D4Mit42 CATGTTTGCCACCCTGAAAC CCTCACTTAGGCAGGTGACTC HEX 109 101
D5Mit146 TTAAATCTGAAGGTGTGGCTATAGC GAGATTGCAAGTAAAGTGAGAGAGG TET 133 129
D5Mit348 CTGACCAGAACACAGCATAGTACA TTTAAAATAGGAAAAGCATTCTTTCC FAM 130 140
D5Mit387 CCCCATGTATCTCTAGATTAACAATG GCACTCGTGTACATAACCAAATAC HEX 181 189
D5Mit352 CCCAGAGCCCACATCAAG TAGGTGGGTGTGTCTCTCCC TET 120 127
D5Mit106 GTCAGGCATGGTGATTCCAT ATGGATGACTGTGAACATACAACT FAM 170 160
D5Mit183 TATAAAGATAATCAGGGCTTAAACTCG ACCTCCACAACATGAGCACA HEX 120 122
D5Mit254 GTGCAGGCCTGAATTGAAAT CAAAGTGCCTGTGCATGTG TET 143 131
D5Mit201 GAGGACTCCTTCGATTTCCC TTCCTAAGCAGGAACTGACCA FAM 117 111
D5Mit18 CTGTAGTGGGTGGTTTTAAAATTG ATGCCACTGGTGCTCTCTG HEX 245 227
D5Mit91 TCTGCAGGTGTCTTCTGCC CTTAGCTTTTACCTGTCTGCACC TET 211 225
D5Mit277 GTGTGTTTGTGCATGGGTATG ACCATCGGGAAAAAATGTAGC FAM 131 147
D5Mit210 GATGGGTGCATTCATCCTG TGAAAGTGATTCCTCAGGGG HEX 201 213
D5Mit95 TGTTCTTGTCCATGTCTGATCC AACCAAAGCATGAAACAGCC TET 123 141
D5Mit163 AATTAGATTAGAAGTGCTGGGTCG GCTCAAAGAGTTCCAATTCCC FAM 174 152
D5Mit99 CAGAAAAGAGAAAACGGAGGG TTCCTGCTGCCTGAAGTTTT HEX 105 211
D5Mit409 GACACAGTTTGGTCACTTGCA ACACACTCTCTCTATTCCACTTTCTG TET 205 221
D6Mit138 GCTCTTATTAATGAAGAAGAAGGAGG CAAAGAAAGCATTTCAAGACTGC FAM 118 142
D6Mit83 TTCTGTAAATTGCTAATCTGTCCA TTGTATGCATTTAACAACTCAGGA HEX 157 137
D6Mit159 CATATTCAAGACGGAGACTAGTTCC CACATGAAACACATGCACACA TET 123 147
D6Mit268 AGTCAGAATATGGCAAGTCAGTG TTTCAGAGTCTTTCTTTCAGTATCTCC FAM 130 117
D6Mit274 GCAATGCCAAAATGTTCAAA TCCTTCTCCATTTACACTTACAACA HEX 122 102
D6Mit384 AATGCTTTATATGCAAACTACTCTCTC GAATATAGCAAGACAAGGGAGACA TET 133 155
D6Mit209 CTCCCCCTCTGTGTGATTGT TTATTACACCAGACCCATGTGG FAM 141 145
D6Mit284 GGCTGCTGAGAAACAACCTC TGAGTATTGAGCCAAATCCTCC HEX 152 150
D6Mit132 TTGTTGTTTTTTACCTCTCATTGG GATCACGAGACTACGGAGGC TET 227 207
D6Mit36 ACCATCTGCATGGACTCACA GTTGAAGAGGACGACCAAGTG FAM 203 185
D6Mit62 CTCACCCACACTCCTGTTAGC TTGTGTGTGATAGACTTACTGGGG HEX 297 173
D6Mit335 CTATGATATGTGCGCGCG AGTAATTCAGACACCAATTAAAATTTT TET 131 125
D6Mit219 AAATGTTGACTTTAATGAGGTAATTG TTCACATATCCCTCAGACATGC FAM 195 185
D6Mit59 GCCATCCTTTGTAATAACAAACA CGTCTGGGAAAACCTCAAAA HEX 175 185
D6Mit15 CACTGACCCTAGCACAGCAG TCCTGGCTTCCACAGGTACT TET 267 202
D6Mit374 TTCTGGCTCTTAACAGTCTGTCC TACATATGCCAATGATATTCTCCC FAM 185 153
D7Mit21 GGGTTGAACCTTACAGGGGT ATCAAACCAGCCCAAGTGAC HEX 135 139
D7Mit191 TTGGGTTTGTACTACCTAGATACCTC CCTCTAGGGCTCTTGCACAC TET 158 190
D7Mit266 TCAGGGATGTCTTAAAACTGGG CGCTGTAAAGCGTATTCGTG FAM 129 123
D7Mit224 CCATGCAGAGGTTTGGAAGT CCCAATGTTCTTGATTCCCA HEX 138 150
D7Mit228 ATTCTTGGCCTTTTCTTGTAACA AAACCTCCACACTGACTTCCA TET 155 147
D7Mit229 GGTTCTCTTTCCTTGTTTGCC TACTGGTTACATCTGGTGGGTG FAM 130 150
D7Mit248 AATCAGGCAACTCAGGCACT TCCTTAGGTCTCCAGTGAAAGC HEX 115 119
D7Mit346 CTCCTTTTTGGTACATATATACACACA ACACTGGAGAGCCAGGAGAA TET 103 109
D7Mit163 GGACAGACACCCTCACCG CGGCTGTGAGAGCATAGTGA FAM 200 150
D7Mit31 TTCAAACCATCCAGTAAGTCCA TTGGTGAACTGCTTCAATGC HEX 253 233
D7Mit323 TTTCACCTTCTAATCCTACTTCCTG TGTCCAGAACAGGAAATAGAGTACC TET 123 149
D7Mit281 TTCCTCTACCTCCTGAGCCA GCCACAAGGAAGACACCATT FAM 120 210
D7Mit66 TTCACTCCCAGCCAGTCTCT TAACCAGGAAACACACGAACC HEX 171 155
D7Mit105 AGCAAAGTAAGGCAGACTTTGG AGGAGAGGCAGAACATGGAA TET 267 249
D7Mit109 TCAACACCAGGAAGTCTCTTCA CCTCCATCTCCCATCCAATA FAM 119 115
D7Mit259 CCCCTCCTCCTGACCTCTT GTCTCCATGGGAACCACACT HEX 155 159
Expected fragment lengths
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Marker name Forward primer Reverse primer 5' - Label C57BL/6J C3H/HeJ 
D8Mit155 TTGGACAGGGAAAATTCTGC TGAGGACTTGCTTTAAGAGTACTCC TET 158 122
D8Mit124 CAACTGTGTATCATAAACTGGGAA GAAGAATCACTCAGCAGTGTATGG FAM 136 142
D8Mit289 AAAAAGAAAAGAAGGCTTAGTAATGTG CTTGCTATTCATTGCAAAATTCC HEX 159 125
D8Mit63 TCTGGAACACAGTCCAATTCC ATATGTGTGAGGGTTTTACCGG TET 215 229
D8Mit190 CTTTGTTGCTGTTTCATTCTGG AGTCATATACAAGGTCAACCTGAGC FAM 145 123
D8Mit339 ACCTATGGTACACACACATCGC CAAACATTTTTAGGCATTTAGATCC HEX 129 113
D8Mit231 TGCAAAGAAAAAAGTATCAAAATTG TGTGTCCTATTTGCAATGTAACTG TET 149 167
D8Mit135 TTGTTTTAAAAGGAAGGTCTATTTTAG CAGAGCCCACATGACAGAGA FAM 207 181
D8Mit80 TGCATTTGTCAGGGCTCTC ATGACACATGAGCCTCCACA HEX 115 141
D8Mit242 TGTGCAACCAATTTCTTCCA CCCATGATTTATTCAGACTGAGG TET 173 203
D8Mit113 GGTCACATAATAAGAAAGCCCG AACCCGTTAGGAGGACCG FAM 145 167
D8Mit271 GGCAGAACCACAGGTTGATT GGAATGAGGTTTGGGTCAAA HEX 103 127
D8Mit89 TGTTTTGAATCTGTTATTAGGTGTG GAGAGAAAGGAACAAATTTATCAAGG TET 139 129
D8Mit49 TCTGTGCATGGCTGTGTATG TGGTGTGCTGCTGATGCT FAM 159 161
D8Mit13 CCTCTCTCCAGCCCTGTAAG AACGTTTGTGCTAAGTGGCC HEX 105 98
D8Mit280 CATGCAATTCCAATGTCAGTG TAGCACTCAATCAAACCCCC TET 115 167
D9Mit126 GCTGCCAATCAGGTAAAGGA GGGGTAGGTATCTGAGCAAGG FAM 134 136
D9Mit1001 ATATCAGGCATGCATTATGATCC TCTCTCTAGTGGGATTATCAACACA HEX 129 139
D9Mit2 GTGGTCTGCCCTCTTCACAT CAAAGCCAGTCCAACTCCAA TET 182 189
D9Mit328 CATTTACTGTCTCTCTTTCATTCTCTG CTTACATCTGGTCCACAAGAAGG FAM 191 237
D9Mit129 TTGTCTTTTAACCTCCTGGAGC TCCCATCTTTCTCCTTGTGG HEX 139 157
D9Mit162 ACCACCAAATACAACCACTTCC GACTGAACAATCAGGAGTATGGC TET 147 129
D9Mit208 GCCTCTCTTTCTTTAAACACTTTAAG CCTCCACACACCTGTTTGTG FAM 119 93
D9Mit75 AGACTGTGACTTACTACGGCTTCA CACACATCTCCCTGTCCCTT HEX 203 151
D9Mit269 TTTTTGGACTAATAGTCAACTGTGTAA AGGAAGACTGAAAACTTGTGGG TET 183 155
D9Mit110 CCAGAAGGGGTGTGTTTTGC CTACCCTCCTTTCTAGTTTTTGTCC FAM 82 157
D9Mit35 CCAGCGCACTGTTCTGATAA AGGTGCCTTCTGCTTTGAAA HEX 131 119
D9Mit53 ATTCATGTGTCTCCAAAATCCC CAAACTCTTGCTGGGTGTGA TET 219 211
D9Mit214 AGCACAGGAAAAGGACGCTA AACCTGTCTCTGTAAAACTATCTCCA FAM 147 123
D9Mit279 CTCCAGAAACTTGTCCGCTC AATTGAAACTGTATCTAAGGCATGG HEX 153 143
D9Mit18 TCACTGTAGCCCAGAGCAGT CCTGTTGTCAACACCTGATG TET 187 217
D10Mit49 GGAATTTACACTGGAATACAACCC GTGGGCATTTGCACTGTG FAM 113 115
D10Mit189 TGTGTAGGTATGTGTGTGCATAGG ATCAGACAGCACCTGGGAAC HEX 113 137
D10Mit213 CTCCTCCTACTGATTGTCCCC GGGACAAACTTTTAAAAATTGCA TET 157 143
D10Mit86 TTTGCCTGTAACAAGCCAGA TTGAGGCTATCAGTTTAAAATCCC FAM 163 157
D10Mit126 ACATTCACAAAATGTGTATGTATGTG TGTTTTTCATTAATCTCTTGAGATGG HEX 136 132
D10Mit38 CGATGAGCCCTAACACCAAT CCTGTTACAAACTAAACCAAACCC TET 173 203
D10Mit130 TGCCACACAAACACCACC ATTCATCAGTGTGAAATATGGCC FAM 157 165
D10Mit31 CATAAGGAGCACAGGCATGA CCCTCTACGTGCATGCTGTA HEX 159 161
D10Mit139 AAGTAAATGAGCAGGATGAAAACC GGGTATGCTGACAGCAAGGT TET 158 154
D10Mit42 GCATTCAGAAGCTGGAAAGG TGCCCAGCATATGTTTAAAGG FAM 191 203
D10Mit95 CCAGTCTCAAAACAACAACAAAC TTGCACCTAGATTGCCTGA HEX 208 174
D10Mit96 ATGTCCAAAACACCAGCCAG GGAAGTGATGGAGCTCTGTT TET 160 134
D10Mit233 GTGCTTTATATTGGAGATCATCACA GTCCCGAATTTCACATACATAGC FAM 137 115
D10Mit180 GACCTTCCTTTATACACAAGTCATAGC GTGGTACAGAACTTAGGTGTTTAATTG HEX 141 213
D10Mit103 TATGCCGACAATATTTCATTGC GCCTCTGCATACATACCAATACC TET 149 151
D11Mit71 GCCATACCTGGTAGCGTGTT AATTTTCAGATGTAGCCATAAGCC FAM 221 245
D11Mit2 TCCCAGAGGTCTCCAAGACA CCACAGTGTGTGATGTCTTC HEX 129 144
D11Mit295 GTTCTAAAATGCAAGTCCCTGG CTCTTTGATACCCCCACCCT TET 119 123
D11Mit163  AACCCTGCTATTGTGCTGCT CTAGAACACACATGCATGCTCA FAM 144 162
D11Mit296 TAGGGCATATTAAAATATAAAGGCTG CTGCACCAATGGTTTATATTTCC HEX 127 103
D11Mit86 TTGACATTGTGACAAAGACTTTCA AAGGCATCATGAGGTTTTTAGTG TET 133 141
D11Mit242 GAAGCCAGCAAGAAAAATGC CTGTCTGGTAGTGCAGCCAA FAM 129 143
D11Mit351 GTATGTGAGGGAGAGTACTCACATG TCTCAGTAACATGAGATATTCAGTGTG HEX 117 111
D11Mit29 TTGAGGCATGAGGGGATTAG TTTCCGTCATTGCTAAAGGG TET 151 157
D11Mit245 ATGAGACCATGCTCCTCCAC TTGTCCTCTGACCTTCACACC FAM 159 147
D11Mit356 GGCAAGCAACTTCTTCCATC TTCAGAAATTTGGGTATTAGAGTGG HEX 103 123
D11Mit285 CATGAATCCATCACCAGCAG TTTTTCAGTCATGCAGGCAG TET 128 139
D11Mit289 CTTTGGTTGGTTTTAAATGTTTTAA AAGGAGAAAGCAGATTCATACACA FAM 133 126
D11Mit198 TGAAAATATGCAGCCTCCG ATCTGCAAAGGGATCTGGTG HEX 293 305
D11Mit258 AAACAGAGATAAACCACGGGG TGTGGAACTAACTCTCAGAAGGC TET 137 177
D11Mit214 CATACAGCCTTCAACAATGACA ACTGCATACATGTGCACTCATG FAM 156 142
D11Mit337 CCTGGCAACCTTCCACTTTA ACCTTCTGACCTCCACATGTG HEX 121 113
D11Mit104 CACATGATCATACACTGTTTCTCC GCCACGTGTTCTAACCTTCC TET 163 169
D12Mit103 ACTATGGTGAAATCATACCCACG ATCAATGGATCTTTTTTGGTGG FAM 140 142
D12Mit11 TCCCAAATGGAAGACAGGAA CCCTCCCATTGCCTTTTAAT HEX 179 173
D12Mit185 TGGAACTAGAAATCCATGTTAAAGG ACTCAGGTATTTGTGCAATTGG TET 159 137
D12Mit59 AGTGAAATTCAGAGCACAAAAGC ACCCTATATCTCCATGGTACGTG FAM 157 159
D12Mit222 TTTAAAAACAACAACAACAAAAAAGG ATCTGGGTTTTGAAATAAGAGCC HEX 121 127
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D12Mit112 CTTCAGGCCTCCCTGGTAC TGCCTCCAAATATACTCACAAGC TET 161 143
D12Mit210 CTGATGTGAAATTCACAAAGAACC TGGGGCCCACTCTACATTAG FAM 157 167
D12Mit52 CCATCTTCTGGCATTTTGCT AGACAGGAGGGTCCCAAAGT HEX 147 125
D12Mit158 CATTGGGCAATGGAATTTG ATGAGAGAAAACCAGAAACAAAGG TET 154 159
D12Mit239 AAAGCATTTCTTGTTTTATGTAATGTG CATGCATCTGCAACTCGC FAM 97 107
D12Mit101 GCTTTTCCTTATCAAGATATGCG GCAGCAGAAAGAGAGGGAAA HEX 177 125
D12Mit17 TCCGAGTGTTGCTTCTCCTT CCTTAGATGCTCAAGGCTGG TET 187 177
D12Mit144 CCACACATGTGCAGACACAG CTGGCTCTAAACCTTAGCACTAGG FAM 312 316
D13Mit303 AGTTCAAGTTTGAGACAGATTCAGG TTCTCTCGCTTCATAAAGTCCC HEX 131 123
D13Mit3 TCAGGCTCATCCCAGATACC TTTTGCAGAGAACACACACC TET 166 203
D13Mit133 TAGACACTTAATTCTGTGATGAAATGG AGCAAAAGCCCCAGTTAGTG FAM 124 118
D13Mit275 TTAGCAAGGGAACAGAGAGAGG CAATCAAGGTATCCCTGTCTCC HEX 115 123
D13Mit18 TGTATCCAGCTCATCCTGATAGG ACTTCCTTTGAACTTCATGACTTC TET 203 197
D13Mit19 GGTGAGTTGTGTAATGATGGACA AGCAACAGGGCTACTAAACACA FAM 157 159
D13Mit179 GACCAATGCCCTACAATTTCA CAGAAGCAGTTTGTCTTTGTGG HEX 103 89
D13Mit248 TAAAGTAGAAGGCAGCATGAGTG ACCCAAATGTTTTGGATCCA TET 121 101
D13Mit231 GCACGGAGGGAGAAATGTAA GTACTTAGGGACTCTTCAGCGTG FAM 123 151
D13Mit24 TGCATGACTGTGTAATGCTTTG GAAGAACTGGGGAAACTGAGG HEX 213 173
D13Mit159 CCCATTGTCCCTGTTCAGAT AAACCCACCATGAATTAAATGC TET 149 167
D13Mit147 CATCCAGGAAGGCAATAAGG CAAATGCACAGTGCCGAG FAM 115 100
D13Mit30 TTTTTGATGTGTATGCTTGTTGG AAAGAGAAGACGGGGAGGAG HEX 115 119
D13Mit213 GCCTGAAACTCTACATAAAATACATCC AGTTTCATTGCTTTAGTTACATTTTCA TET 155 167
D13Mit292 AAATGACATTTTTGTATGCACACA GAGACAGAGTAATGACCGAATGG FAM 159 145
D13Mit262 CTGCGGCTGTAGGTTAAGTATG AGGCTGCTGCTAACAGATGG HEX 133 123
D13Mit35 GATTTTCCAGGTAAGTGGCG CACATTCACTGTGAGTGCACA TET 197 189
D14Mit48 TTTCTAGCCCTGACCCCC TCTGTTCACTCTGTGTAATTCTCC FAM 125 93
D14Mit207 TCCAACTAGTCCCCCTCTACTT CTGTGACTATCTGTACAAGACCTGC HEX 135 111
D14Mit127 AAACTTTACCTACCAGTGTCAAGTTAG GTGTTGAACAACTCTATGTCTGTCTG TET 154 156
D14Mit60 TATTCCCCTATTTTACACTTTCCG ACCTCAATGGATTTTTAAAAGTGG FAM 143 119
D14Mit259 TGGTGTCTCCTTCGGAATTT TAAATGTAAAAGGTAAAGGCAATGG HEX 133 153
D14Mit5 CACATGAACAGAGGGGCAG GTCATGAAGTGCCCACCTTT TET 185 111
D14Mit157 GGTTGACCTCTGACCTCCAC AATAGCACTGGAATTAAAAATGTGG FAM 157 153
D14Mit85 TCCCACATATGCACATACACG ATTCTGATTGCAGATTCCGG HEX 167 163
D14Mit68 GTGGCATGCACAACCGTATA CCCTTTTGAGGTGCTTGTTT TET 161 163
D14Mit263 TGAGCACAGAGCCTATGTGG ACAGAGAAATACCATGAAAACACC FAM 129 125
D14Mit106 CATAGGCTCTAGCGCTGACC ATTGCATTGATGTCATAATTTCA HEX 316 314
D14Mit166 TGGGGTTAGAGTAACTAGAATATAGGG GGGGGCATTGTATGCTTAAA TET 151 135
D14Mit97 TCAGTCCAAACTCTGTTAATCTTCC CAGCTCCACATTTTTGCTCA FAM 162 168
D14Mit266 ATGCACAGGATTGATCTGCA AGCATGACCTAAATAATGAGACCC HEX 155 183
D15Mit102 TATGGAACACACACAAGCATACA TGATCATTCATGAATAGGTTGAGG TET 208 195
D15Mit256 CCACCCTTCCAAGTTCTTATACC GGAATGGCTAATAAATAAAGACTCTTG FAM 125 167
D15Mit138 TTCAATTCCCTTTTGTCAAATG CAAGACCCTAGATTCAGTCTACCC HEX 156 134
D15Mit152 AAATGTAGGACTTACACAGTTTGTGC CAAAGTTTAGTGTCAGAACGAATACA TET 113 89
D15Mit229 AGAGTGATTATTTACAAGAAACACACA GATTAATGTTTAAAATCATGGCTGC FAM 117 147
D15Mit88 TAGCAATCACAGGAGGAATTAGG TTACTGAACTTAAGAACTGGAATCATT HEX 216 208
D15Mit209 TTGTGCTTCACTAGATGTAGACCA TTTTATAGTTGCACATAAGCAGCA TET 134 113
D15Mit156 CCCACATTCATGCACATATAGG AACAAATCAAGAACCAATTGGG FAM 152 130
D15Mit188 TTCACTCCAAATCCTCCGAC GAAGAGGAAATGCAAGCCAG HEX 170 189
D15Mit107 CAACACTTATACACTTGTGTCAGGG TCATGGTTGGAACAGCAGAC TET 158 152
D15Mit43 GAGTTTGGTTCGGTTGTAGAGG CTGGGTACCTCAGCTTTTGC FAM 211 227
D15Mit44 ACCTGCATAGATGTTGAGTCACA AGGCACAAAAGGAGCAGAGA HEX 157 155
D15Mit79 CGAAACATTTGGGCACTTG CCCCATTCCTGAGTCTCTTG TET 283 289
D15Mit161 TCTGTTTTGTTTGTTCGTTTGC TAAAATCTCCCTGTATACAAGTCTGTG FAM 135 109
D16Mit107 ACCCCATGAGACTCAGCATC GAAAGCCTGAACACATGGGT HEX 197 199
D16Mit100 AGTCTTGTCCGCGTCAGAAT AAAAGGATTGCAGGGACTACTG TET 154 160
D16Mit144 AACTATCCAGGCCACAGTCTG CAACCGCATTAGTCAGGGTT FAM 153 157
D16Mit101 TTATGAAATGTTTTATCTTTTGGGG CTCCAGATGTAGAAATTAAAATCTTGG HEX 157 153
D16Mit134 ATGGGAAGCAATCAGTAATAACTG ACCACATAGACATCATGGTATACACA TET 157 165
D16Mit12  GAACTCAGTAAGCTCTCTATGCCC GGAGGACTAGCAGGCTAGAGC FAM 199 163
D16Mit42 TAACCATCACATTCTTTTTCATGT TGTGGCATAAGGCAGGCT HEX 135 159
D16Mit30 GTGCACATACATACCACAGCG TCACTGCAGGGAGGTTCAG TET 159 117
D16Mit140 ATAGTTGAAAAACTTGAACATGCG GAAAAGGTTAATGCTGGTCACC FAM 157 171
D16Mit139 GTATGTAAGGAATGGTCAAATTCTTG TCATTGTGATTGTGAAAGAATGC HEX 155 179
D16Mit27 AGAAAAGAATGAAAATCACGCA TAGAGACCTTTTGTCTGAAATCCA TET 91 81
D16Mit189 ACAGTGTTTGTTTGTTTGTTTGTG CAGTACAGGAAGTCTTTGCATCC FAM 206 192
D16Mit70 GGATCTATATGCTATAGAACCATTCA GTCATCAATTCCATTTCCTAATATAGA HEX 196 176
D16Mit86 TAATGTGGCAAGCAACCAAA GCATGTTTCCATGTGTCTGG TET 135 129
D17Mit164 AGGCCCTAACATGTAGCAGG TATTATTGAGACTGTGGTTGTTGTTG FAM 143 133
D17Mit133 TCTGCTGTGTTCACAGGTGA GCCCCTGCTAGATCTGACAG HEX 202 174
Expected fragment lengths
Supplement  84 
Supplement table S1. Continuation. 
 
 
 
 
 
 
 
 
 
 
 
 
Marker name Forward primer Reverse primer 5' - Label C57BL/6J C3H/HeJ 
D17Mit29 CATCTTTCCAGTCCAAATCTCC CTTCTGGCTTCCTCAACCC TET 157 153
D17Mit33 TGTTGGAGCTGAATACACGC CCAAACACCAGGGTCTCTGT FAM 201 179
D17Mit49 TCTTAGAACTCACATCAATGCCA TCCAGGGACCTTTTGTCTTG HEX 257 231
D17Mit180 AGACACTGTCTAAAAACACAAGATGG TTGTGTTCATATGCATGTGTGC TET 155 157
D17Mit20 AGAACAGGACACCGGACATC TCATAAGTAGGCACACCAATGC FAM 187 177
D17Mit119 CCTCCTGTTCTGAACTTCAGC TCGATGCAACCCAGTATAAAA HEX 153 145
D17Mit218 GGAGAAGATGGGAGAAAGGC CAAAGCATTTCCAAGCATAGG TET 123 103
D17Mit142 AATATATATATCCTGGAGCCAACACA ACCTTTATGAAGTTATGCTGAGTATCA FAM 154 128
D17Mit76 CTCCTCACCCAGATTCTTGTAA TTTCGCAAGTTATTTTAACCCG HEX 131 97
D18Mit64 TCAGATTCACTGCTAAGTCTTTTC AGCAAGAAAAGCAGGTGAGG TET 159 179
D18Mit116 CCTTAAAGGAGTGTGTATATTTTTGTG TTGATGTTATCCTCTGGGCC FAM 140 96
D18Mit34 CACTGGATGACACAGCCTGT GATGTTTCCTTGGGTTTGTCA HEX 141 149
D18Mit119 AGATGCTTGTGAAACATACATATGTG GAGTGTATAGCGGACTTTTGGG TET 162 136
D18Mit177 CTGTAGTTTATCAGTTCACCCTGTG TGTGCTGTTAAACAAATATCTCTGG FAM 179 175
D18Mit74 AGCCAGAGCTACAAAGTTTCAA GCTCTTGTAGAGCCATCATTCC HEX 227 191
D18Mit124 CCCAAATGGGGTGTCTTTTA CTGCCACACATTTGTGTGTATG TET 158 146
D18Mit40 GGTAGGAGTCACTTTCCGTCC TTTTGTGAGCATTTTTATACCATT FAM 149 139
D18Mit184 CACACATGTGTAGGTAGGTAGGTAGG CGCACAAGGACTACTGAAACA HEX 179 134
D18Mit186 AAGTGTTGGGCAAAGGCTAA CTTTAGTATAGTGTGCATGAGTGTGA TET 133 115
D18Mit48 TTGCACTCACAGGGCACAT TCAGAGTTTCCAGAAGACACCA FAM 173 165
D18Mit144 TAGGGTTTTTTTTTTCTTTTTCTCC GATAAAAAAATATGTTCACAAAACGC HEX 187 184
D19Mit59 CTCTAACTATCCTCTGACCTTCACA TTTTAAGCAGAACATTGAGGACC TET 206 146
D19Mit56 CTGAATGTGTATGTGTGCAAGTATG ATTATGAATTCAAGACTAGCCTAGGA FAM 145 137
D19Mit128 GGCAGGAGAATGTATTCAGAAA TCCTCCAACCTGCTTCCTC HEX 130 152
D19Mit96 CTTAACTGCAGTTTTAAAAGACATTTG CATTTGAGAGAATGTTTGAACATACA TET 128 120
D19Mit106 CCTTTTTTTTTTTAACCAGACAGG ATCAATGAATGAAGAACAAATAGTTTC FAM 131 123
D19Mit40 CAGGGTAGTATTGCAGATAATCAA AAAGTTTCTTTGTGTGTGCACG HEX 119 113
D19Mit119 CACCCACATACCTTGATT CTCTCTTTATCTCTCCTCTCTCT TET 271 283
D19Mit13 TCTGGCACAAAGAGTTCGTG CTTTTGCAGGAGCAGGTAGG FAM 253 269
D19Mit90 GTGGGAATCAATTTTAGTATGAACA GGATGCTTGATATCATGTACATACA HEX 139 133
D19Mit83 GACACATGCGGCATACAGTC CTTGCTCTGAGTATTTTAATGACTGC TET 134 112
D19Mit26 TTGTTACACAGCAAAATCCTGC TTGAGGAGTAAGGCAAAAAAGG FAM 139 141
D19Mit6 ATTAGTAAACTGACTCCCATGCG CTCATGAGTCCCCTGGGTTA HEX 119 123
DXMit54 ACATCTGATGTGGATGTTCAGC CTCCGATGGAAACTGTTGGT TET 199 151
DXMit81 GAGGAGCATCAACCTTCTCG GAGGTGGGGAGAAACAGAGG FAM 206 200
DXMit105 AAATTGGAGTGACCTCAGATTTG CCATGTTTCTCACCATGAAGA HEX 157 153
DXMit140  ACATGAAAGTTAGAAAGAGACCCG GTGCACATTTGTGTGTGTATGC TET 115 129
DXMit46 CTTTCCTGAGTGCCTCTTGG TTCTGAATCTGTAATCTGTCTGGC FAM 257 253
DXMit119  CTTTAACCATAATAATGGCCTTGC GGGTTCTGTGATCGCAAGTT HEX 161 175
DXMit93 TTGTCAGAATGATCGATTCTTATATC CACCCAAAGTAGTTAGATCTTATCATT TET 207 209
DXMit16 CTGCAATGCCTGCTGTTTTA CCGGAGTACAAAGGGAGTCA FAM 125 93
DXMit170 TGCAGGCACTAACAGTGAGG TAGTTTCACTGTGCCATTGTATACA HEX 123 129
DXMit64 GGATCAGTTAGCAGGGAAAGG CACAGACTGAGAAGGCTGTCC TET 141 121
DXMit173 ATTTGATGTCCTCGTCTGGTG TAATTATACTGGGGACTAGAACTCAGG FAM 132 136
DXMit130 TTCATATCGCCCCAACCTAC TATTTTGAAACCTCTGCCATTT HEX 175 153
DXMit10 GAATTACAGGCATGCGTCCT TGTTTGACTGAGAGGATGCG TET 247 245
DXMit186  ATCAATGCATAGTATTTGGGCC AATTTGTCACTGCGGGTAGG FAM 135 127
DXMit223 TTGGTTTGGGGTTTTTTTTG ATTCCTGATAATGTCTTCTGGACA HEX 112 116
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